Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1619589 10.3389/fphar.2025.1619589 Pharmacology Systematic Review Efficacy of botanical extracts for knee osteoarthritis: a network meta-analysis of randomized controlled trials Yan et al. 10.3389/fphar.2025.1619589 Yan Chao 1 † Du Xiaotao 1 † Liu Yan 1 Xia Fan 1 Yu Hongling 1 Zhu Yongliang 1 * Bao Tianyi 1 2 * 1 Department of Orthopaedics, Nanjing Central Hospital, Nanjing, China 2 Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China

Edited by: Mojtaba Vaismoradi, Nord University, Norway

Reviewed by: Eduardo Martins Sousa, Universidade CEUMA, Brazil

He Cai, Guizhou University of Traditional Chinese Medicine, China

 *Correspondence: Tianyi Bao, 526694210@qq.com; Yongliang Zhu, 75032573@qq.com

These authors have contributed equally to this work

 07 10 2025 2025 16 1619589 28 04 2025 17 09 2025 Copyright © 2025 Yan, Du, Liu, Xia, Yu, Zhu and Bao. 2025 Yan, Du, Liu, Xia, Yu, Zhu and Bao

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 Background

Traditional botanical drugs and medicinal plants, along with their metabolite extracts, have exhibited considerable potential in the management of knee osteoarthritis (KOA) due to their natural properties, favorable safety profiles, and minimal adverse effects.

 Objective

This study aimed to evaluate the therapeutic efficacy of various botanical and medicinal plant extracts on KOA. Search Methods: We conducted a comprehensive literature search across PubMed, Embase, Cochrane Library, and Web of Science, focusing exclusively on randomized controlled trials (RCTs) that investigated the efficacy of botanical and medicinal plant extracts for KOA. Selection Criteria: Studies were included if they met the following criteria: (1) experimental groups receiving single botanical drugs or plant extracts for KOA; (2) control groups comprising patients receiving placebo or standard care; (3) clinical RCT designs; and (4) outcome measures including at least one of the following: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Visual Analogue Scale (VAS), Short Form 36 Health Survey (SF-36), Knee injury and Osteoarthritis Outcome Score (KOOS), Lequesne’s Pain-Function Index (LPFI), Japanese Orthopaedic Association Score (JOA). Data Collection and Analysis: The methodological quality of the included studies was assessed using the Cochrane risk of bias tool, and data analysis was performed using appropriate statistical software.

 Results

A total of 36 RCTs, encompassing 3,285 participants, were included in this review. Network meta-analysis revealed that compared to the placebo control group, Cucumis sativus (CS) extract [MD = 6.65, 95% CI = (3.83, 9.48)] significantly improved pain scores; Ashwagandha extract [MD = 4.16, 95% CI = (2.43, 5.90)] was more effective in reducing stiffness scores; and CS extract [MD = 4.28, 95% CI = (2.08, 6.49)] significantly improved function scores.

 Conclusion

Based on Ranking Plot of the Network, we can state that CS extract is recommended as the most effective botanical and medicinal plant extract for KOA treatment. However, further studies are required to draw definitive conclusions. Given that there are only two studies with high homogeneity but small sample size for CS extract, the first result should be regarded as an exploratory signal and needs to be verified by a large sample multi-center RCT with independent teams.

 Clinical Trial Registration

https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024617459, identifier CRD42024617459.

 botanical extracts knee osteoarthritis system review network meta section-at-acceptance Ethnopharmacology 1 Introduction

Knee Osteoarthritis (KOA) is a degenerative disease primarily affecting the knee joint function of middle-aged and elderly populations (Giordano et al., 2020). Its pathological characteristics include joint space narrowing, subchondral bone sclerosis, and osteophyte formation, with clinical symptoms such as joint pain, restricted mobility, crepitus during movement, joint deformity, and muscle atrophy (Sharma, 2021). Remarkably, KOA has contributed more to the global burden of OA than any other site (Long et al., 2022). With the global trend of population aging, the prevalence of KOA continues to rise, becoming an increasingly serious public health issue worldwide (Menon and Mishra, 2018) and placing substantial pressure on healthcare systems and economies (Bedenbaugh et al., 2021; Jin et al., 2023). Data released by the World Health Organization in February 2021 reported that the number of osteoarthritis patients worldwide had reached approximately 343 million. In China, the overall prevalence of KOA is 8.1%, with rates of 5.2% in individuals aged 50 and above and rising to 11% in those aged 60 and older (Chen et al., 2022). By comparison, the overall prevalence rates of KOA in the United States and Europe are 4.3% and 5.3% (Chen et al., 2022), respectively, further highlighting the extensive impact of this condition.

Currently, the treatment of KOA primarily includes non-pharmacological interventions, pharmacological therapies, and surgical procedures (Charlesworth et al., 2019). Non-pharmacological interventions encompass patient education, moderate physical activity, mobility support, and physical therapy, aiming to reduce joint load, improve joint function, and enhance quality of life. Pharmacological therapies include oral administration of chondroprotective agents such as glucosamine and chondroitin sulfate, as well as analgesics like nonsteroidal anti-inflammatory drugs (NSAIDs) to alleviate pain and suppress inflammation (Kolasinski et al., 2020). Surgical interventions, such as joint replacement surgery, are typically recommended for patients with more severe conditions (Hannon et al., 2023). However, while conventional treatments can alleviate the symptoms of KOA to some extent, they cannot achieve a complete cure. Moreover, long-term use of certain medications may result in adverse effects, such as gastrointestinal discomfort and liver or kidney damage (da Costa et al., 2017). Therefore, the search for safer and more effective treatment options has become a major focus of current research efforts.

As there are currently no specific drugs for the treatment of KOA, traditional botanical drugs or medicinal plants and their extracted metabolites have shown significant potential due to their natural origins, high safety profile, and minimal side effects. The screening of botanical drugs and elucidation of their mechanisms of action are of great importance in the treatment of KOA (Wang et al., 2022). Many botanical and medicinal plant extracts, such as curcumin, ginger extract, and willow bark extract, have been found to possess anti-inflammatory, anti-swelling, and analgesic properties, effectively alleviating the symptoms of KOA. Numerous botanical drugs and their secondary metabolites, including extracts from Scutellaria baicalensis, turmeric, chicory root, frankincense, and ginger, have demonstrated potential therapeutic activity against KOA (Wang et al., 2022). The underlying mechanisms include reducing oxidative stress, inhibiting chondrocyte apoptosis, promoting autophagy, and modulating the NF-κB signaling pathway (Ziadlou et al., 2019). In recent years, significant progress has been made in the application of botanical drugs for the treatment of KOA (Walzer et al., 2015). Multiple clinical trials have indicated that botanical drugs or their active metabolites play an important role in alleviating KOA symptoms. Meta-analyses have shown that botanical medicines exhibit better efficacy in treating KOA compared to placebos and some conventional biomedicines (Lin et al., 2022). Additionally, combining traditional Chinese medicine with Biomedicine has proven more effective than using biomedicine alone (Liang et al., 2022). However, due to potential biases in the included studies, further research is needed to identify the active metabolites of botanical medicines and clarify their mechanisms of action.

Network meta-analysis (NMA) is an evidence-based technique used to compare the effectiveness of multiple interventions for a specific disease and to rank these treatments based on their efficacy (Rouse et al., 2017). In this study, we employed a network meta-analysis to compare different botanical and medicinal plant extracts, evaluate their effectiveness in treating patients with KOA, and provide patients and clinicians with a clearer understanding of the therapeutic potential of these extracts. Our objective is to assess the effects of these botanical and medicinal plant extracts on KOA patients and provide evidence-based recommendations for both patients and clinicians.

 2 Materials and methods 2.1 Search strategies

Researchers retrieved data from four electronic databases (PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and Web of Science) spanning from their inception to October 2024. The search strategy was developed based on the PICOS framework: (P) Population: Knee Osteoarthritis; (I) Intervention: botanical and medicinal plant extracts; (C) Comparison: Placebo or conventional treatment measures; (O) Outcome: Functional scores of patients with knee osteoarthritis; (S) Study design: Randomized controlled trials (RCTs). The detailed search strategy is presented in Supplementary Table S5. The PICOTS framework is detailed in Supplementary Table S6.

 2.2 Inclusion criteria

1. Experimental groups of various single botanical drugs or plant extracts for knee osteoarthritis included: Zingiber officinale Roscoe [Zingiberaceae; Zingiberis rhizoma] (Ginger), Ananas comosus (L.) Merr. [Bromeliaceae; Ananasis caulis] (Pineapple, bromelain), Boswellia serrata Roxb. ex Colebr. [Burseraceae; Olibanum indicum] (Indian frankincense, BS), Passiflora edulis Sims [Passifloraceae; Passiflorae edulis pericarpium] (Passion fruit peel, PFP), Derris scandens (Roxb.) Benth. [Fabaceae; Derridis scandentis caulis] (DSB), Curcuma longa L. [Zingiberaceae; Curcumae longae rhizoma] (Turmeric, Curcuma), Sesamum indicum L. [Pedaliaceae; Sesami semen] (Sesame), Prunus cerasus L. [Rosaceae; Pruni cerasi fructus] (Tart Cherry), Olea europaea L. [Oleaceae; Oleae folium] (Olive leaf, OL), Punica granatum L. [Lythraceae; Granati pericarpium] (Pomegranate), Elaeagnus angustifolia L. [Elaeagnaceae; Elaeagni angustifoliae fructus] (EA, Russian olive), Withania somnifera (L.) Dunal [Solanaceae; Withaniae radix] (Ashwagandha), Argania spinosa (L.) Skeels [Sapotaceae; Arganiae oleum] (Argan), Camellia sinensis (L.) Kuntze [Theaceae; Theae folium] (Green tea, GT), Psidium guajava L. [Myrtaceae; Psidii guajavae folium] (Guava leaf, GL), Momordica charantia L. [Cucurbitaceae; Momordicae fructus] (MC, bitter melon), Cucumis sativus L. [Cucurbitaceae; Cucumeris sativi fructus] (CS, cucumber), Allium sativum L. [Amaryllidaceae; Allii sativi bulbus] (Garlic), Andrographis paniculata (Burm.f.) Nees [Acanthaceae; Andrographidis herba] (AP), Foeniculum vulgare Mill. [Apiaceae; Foeniculi fructus] (Fennel), Chrysanthemum zawadskii var. latilobum [Asteraceae; Chrysanthemi flos] (CZ), Rubus idaeus L. [Rosaceae; Rubi idaei folium] (RIL, raspberry leaf), Nigella sativa L. [Ranunculaceae; Nigellae semen] (NS, black seed), Perilla frutescens (L.) Britton [Lamiaceae; Perillae folium] (Zisu), Delphinium denudatum Wall. ex Hook. f. and Thomson [Ranunculaceae; Delphinii radix] (Jadwar), and Drimia maritima (L.) Stearn [Asparagaceae; Scillae bulbus] (SO, Squill oxymel); All botanical drugs were selected and reported according to the guidelines of the “Consortium for Phytochemical Characterization of Medicinal Plants (ConPhyMP)”; (2) Control groups consisting of patients who received only placebo or usual treatment; (3) Study designs limited to clinical RCTs; and (4) Outcome measures that included at least one of the following: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Visual Analogue Scale (VAS), Short Form 36 Health Survey (SF-36), Knee injury and Osteoarthritis Outcome Score (KOOS), Lequesne’s Pain-Function Index (LPFI), Japanese Orthopaedic Association Score (JOA).

 2.3 Exclusion criteria

1. Studies with incomplete data or unreported data; (2) Non-RCTs (including quasi-RCTs, animal studies, protocols, conference abstracts, case reports or correspondence); (3) Study on mixed preparations of various botanical drugs or plant extracts; (4) Research on synthetic drugs with similar composition to botanical drugs or plant extracts.

 2.4 Study selection

The EndNote reference management software was used to screen and exclude studies. Two researchers initially screened the titles of studies to identify duplicates, non-RCTs, review articles, conference papers, protocols, and correspondence. Subsequently, the abstracts of the studies were reviewed by the two researchers to determine eligible and ineligible studies. Finally, the full texts of the remaining studies were independently reviewed by the two researchers to further confirm the studies for inclusion. During this process, the two researchers independently conducted the screening and compared the remaining studies. If their decisions were consistent, the studies were included. In cases of discrepancies, a third researcher was consulted to resolve the issue through discussion.

 2.5 Data extraction

This study utilized a standardized, pre-specified data extraction form with seven items to record the following information: (1) author, (2) publication year, (3) country, (4) study duration, (5) sample size, (6) mean age, and (7) details of the intervention.

 2.6 Risk of bias in individual studies

Two researchers independently assessed the risk of bias (ROB) using the Cochrane Handbook version 5.1.0 to evaluate the ROB in RCTs. The assessment considered the following seven aspects: (1) generation of the random sequence; (2) allocation concealment; (3) blinding of participants; (4) blinding of personnel; (5) blinding of outcome assessors; (6) incomplete outcome data; and (7) selective reporting. Based on the number of metabolites with potentially high ROB, trials were categorized into three levels of ROB: high risk (five or more metabolites), moderate risk (three or four metabolites), and low risk (two or fewer metabolites) (Higgins et al., 2011).

 2.7 Data analysis

In studies using botanical and medicinal plant extracts as interventions, all variables were continuous and were expressed as means with standard deviations (SD) (Li and Chen, 2021). Continuous variables were reported as either mean differences (MD, defined as the absolute difference between the means of the treatment and control groups, calculated using the same scale) or standardized mean differences (SMD, defined as the mean difference between groups divided by the standard deviation of outcomes among participants, used for pooling trial data from different scales) along with their 95% confidence intervals (CI) for analysis. The effect sizes are categorized as negligible (SMD <0.2), small (0.2–0.49), moderate (0.5–0.79), or significant (≥0.8). For interpretation, we apply the same evaluation criteria to the absolute values of SMD: negative SMD values (indicating better outcomes in the intervention group) are still assessed using the same evaluation standards after converting to absolute values. Given the potential heterogeneity across studies, a random-effects model was selected for analysis instead of a fixed-effects model (Jackson et al., 2011).

We used Stata software (version 15.1) in accordance with the PRISMA-NMA guidelines (Moher et al., 2015) to perform NMA aggregation and analysis within a Bayesian framework using Markov chain Monte Carlo (MCMC) simulation. To ensure the validity of the NMA, we carefully assessed transitivity and consistency, which are critical assumptions underlying indirect treatment comparisons. Transitivity was evaluated by examining the distribution of key effect modifiers (such as patient demographics, baseline severity of KOA, intervention doses, and study duration) across the included studies. We considered the assumption plausible if the populations, interventions, and outcomes were sufficiently similar to allow for meaningful indirect comparisons. Consistency was evaluated by comparing direct and indirect evidence using both local (node-splitting) and global inconsistency models. Statistical evidence for inconsistency was considered significant if p < 0.05. Deviations from transitivity or consistency assumptions were documented, and sensitivity analyses were performed to test the robustness of the results (Salanti et al., 2011).

Stata software was used to generate and describe network diagrams for different exercise interventions. Each node in the generated network diagram represents a specific exercise intervention or control condition, and the lines connecting the nodes represent direct head-to-head comparisons between interventions. The size of each node and the thickness of the connecting lines were proportional to the number of studies included (Chaimani et al., 2013).

The intervention hierarchy was summarized and reported using P-scores. P-scores are considered frequency simulations under the surface of the cumulative ranking curve (SUCRA) values, measuring the certainty of one treatment being better than another across all competing treatments, on average. The P-score ranges from 0 to 1, where a score of 1 indicates the best treatment with no uncertainty, and a score of 0 indicates the worst treatment with no uncertainty. Although P-scores or SUCRA values can effectively be reinterpreted as percentages representing the effectiveness or acceptability of interventions, these scores should be interpreted cautiously unless there are clinically meaningful differences between interventions. To examine potential bias in small-scale studies, which could lead to publication bias in the NMA, a network funnel plot was generated and visually inspected for symmetry (Khera et al., 2016).

 2.8 GRADE evidence assessment

We applied the GRading of Recommendations Assessment, Development and Evaluation (GRADE) framework to rate the certainty of evidence for the three primary outcomes: knee pain intensity, knee stiffness severity, and limitation of knee function. RCTs begin as high-certainty evidence. We then evaluated five potential downgrade domains: (1) risk of bias, (2) inconsistency, (3) indirectness, (4) imprecision, and (5) publication bias, lowering the grade one level for each serious limitation identified. All included studies were RCTs with no serious risk of bias, indirectness, or imprecision; however, serious inconsistency was present for every outcome. Consequently, the certainty of evidence was downgraded by one level for each outcome, resulting in a final rating of moderate certainty.

 3 Results 3.1 Study identification and selection

A total of 2,330 articles were retrieved from electronic databases, along with an additional 13 articles identified through manual searches. After removing duplicates, 1,732 articles remained for title and abstract screening, after which 1,603 were excluded. The remaining 129 articles underwent full-text review, resulting in the exclusion of another 93 articles for reasons including non-RCTs, incomplete data, conference papers, or failure to meet the inclusion criteria for interventions. Ultimately, 36 articles were included in this study (Figure 1).

Flowchart of literature selection.

Flowchart detailing study selection for a meta-analysis. From 2,343 identified records, 611 duplicates were removed. After screening 1,719 records, 1,254 were excluded. From 465 reports sought for retrieval, 336 were not retrieved. Among 129 assessed for eligibility, several were excluded due to incomplete data or not meeting criteria, resulting in 36 studies included in the qualitative synthesis. Manual searches added 13 records, with 10 not retrieved and 3 excluded for incomplete data. 3.2 Quality assessment of included studies

A total of 36 RCTs were included in this study. Overall, the quality of the included studies was moderate. Specific details will be presented in Table 1.

Characteristics of the studies included in the meta-analysis.

Author Country Year Age (mean + SD) Total/male/female Intervention Control Outcome
Altman United States 2001 T: 64.0 (11.5) T: 124/50/74 Ginger extract Placebo WOMAC, SF-36
C: 66.3 (11.6) C: 123/45/78 Length of Intervention: 6 weeks
Freq: 2 times a day
Single dose: 255 mg
Wigler Israel 2003 T: 64.7 (NA) T: 14/1/13 Ginger extract Placebo VAS
C: 59.3 (NA) C: 15/5/10 Length of Intervention: 12 weeks
Freq: 4 times a day
Single dose: 250 mg
Brien United Kingdom 2006 T: 62.83 (9.36) T: 24/13/11 Pineapple extract Placebo WOMAC,SF-36
C: 60.43 (7.63) C: 23/11/12 Length of Intervention: 12 weeks
Freq: 1 time a day
Single dose: 800 mg
Sontakke India 2007 T: NA T: 33/NA/NA Boswellia serrata extract Usual treatment WOMAC
C: NA C: 33/NA/NA Length of Intervention: 6 months
Freq: NA
Single dose: NA
Farid Iran 2010 T: 55 (14.1) T: 17/5/12 Passion fruit peel extract Placebo WOMAC
C: 49.71 (14) C: 16/3/13 Length of Intervention: 2 months
Freq: 1 time a day
Single dose: 150 mg
Kuptniratsaikul Thailand 2011 T: 59.4 (7) T: 55/8/47 Derris scandens Benth extract Usual treatment WOMAC
C: 60.5 (8.2) C: 52/10/42 Length of Intervention: 4 weeks
Freq: 1 time a day
Single dose: 800 mg
Zakeri Iran 2011 T: 48.4 (11.1) T: 103/20/83 Ginger extract Placebo WOMAC, VAS
C: 45.74 (12.5) C: 101/20/81 Length of Intervention: 6 weeks
Freq: 2 times a day
Single dose: 250 mg
Pinsornsak Thailand 2012 T: NA T: 36/NA/NA Curcuma extract Usual treatment VAS, KOOS
C: NA C: 37/NA/NA Length of Intervention: 3 months
Freq: 2 times a day
Single dose: 500 mg
Sadat Iran 2013 T: NA T: 22/NA/NA Sesame extract Usual treatment VAS, KOOS
C: NA C: 23/NA/NA Length of Intervention: 2 months
Freq: 1 time a day
Single dose: 40 g
Madhu India 2013 T: 56.63 (10.58) T: 30/13/17 Curcuma extract Placebo WOMAC, VAS
C: 56.77 (9.98) C: 30/13/17 Length of Intervention: 42 days
Freq: 2 times a day
Single dose: 500 mg
Schumacher United States 2013 T: 56.7 (11.3) T: 27/NA/NA Cherry extract Placebo WOMAC
C: 56.7 (11.3) C: 31/NA/NA Length of Intervention: 6 weeks
Freq: 1 time a day
Single dose: 8 oz
Takeda Japan 2013 T: 61.4 (8.3) T: 13/3/10 Olive leave extract Placebo JOA
C: 60.8 (7.2) C: 12/3/9 Length of Intervention: 4 weeks
Freq: 1 time a day
Single dose: 50.1 mg
Kuptniratsaikul Thailand 2014 T: 60.3 (6.8) T: 171/14/157 Curcuma extract Usual treatment WOMAC
C: 60.9 (6.9) C: 160/21/139 Length of Intervention: 4 weeks
Freq: 1 time a day
Single dose: 1500 mg
Panahi Iran 2014 T: 57.32 (8.78) T: 27/5/22 Curcuma extract Placebo WOMAC
C: 57.57 (9.05) C: 26/4/22 Length of Intervention: 6 weeks
Freq: 3 times a week
Single dose: 500 mg
Ghoochani Iran 2016 T: 56.74 (10.23) T: 19/2/17 Pomegranate extract Placebo WOMAC
C: 53.84 (11.95) C: 19/2/17 Length of Intervention: 6 weeks
Freq: 1 time a day
Single dose: 200 mL
Panahi Iran 2016 T: 55.2 (7.8) T: 32/6/26 Elaeagnus Angustifolia extract Usual treatment WOMAC, VAS, LPFI
C: 53.7 (10) C: 32/2/30 Length of Intervention: 7 weeks
Freq: 1 time a day
Single dose: 600 mg
Ramakanth India 2016 T: 58.92 (6.07) T: 20/13/7 Ashwagandha extract Placebo WOMAC, VAS
C: 58.95 (3.73) C: 20/16/4 Length of Intervention: 12 weeks
Freq: 2 times a week
Single dose: 250 mg
Srivastava India 2016 T: 50.23 (8.08) T: 78/25/53 Curcuma extract Placebo WOMAC, VAS
C: 50.27 (8.63) C: 82/32/50 Length of Intervention: 4 months
Freq: 1 time a day
Single dose: 500 mg
Essouiri Morocco 2017 T: 58.24 (8.8) T: 55/4/51 Argan extract Placebo WOMAC, VAS
C: 58.85 (5.6) C: 52/3/49 Length of Intervention: 8 weeks
Freq: 1 time a day
Single dose: 80 mL
Hashempur Iran 2018 T: 56.65 (8.07) T: 20/17/3 Green tea extract Usual treatment WOMAC, VAS
C: 53.05 (11.06) C: 20/15/5 Length of Intervention: 4 weeks
Freq: 3 times a day
Single dose: 500 mg
Kakuo Japan 2018 T: 53.2 (6.3) T: 27/12/15 Guava leaf extract Placebo JKOM
C: 54.4 (7.5) C: 26/9/17 Length of Intervention: 12 weeks
Freq: 1 time a day
Single dose: 1000 mg
May Malaysia 2018 T: 61.97 (9.19) T: 38/NA/NA Momordica charantia extract Placebo KOOS
C: 57.81 (9.15) C: 37/NA/NA Length of Intervention: 3 months
Freq: 3 times a day
Single dose: 500 mg
Nash United Kingdom 2018 T: 51.9 (9) T: 61/33/28 Cucumis sativus extract Usual treatment WOMAC, VAS
C: 52.5 (5) C: 61/29/32 Length of Intervention: 180 days
Freq: 2 times a day
Single dose: 10 mg
Panda India 2018 T: 55.2 (8.58) T: 25/NA/NA Curcuma extract Placebo WOMAC, VAS
C: 53.12 (8.25) C: 25/NA/NA Length of Intervention: 12 weeks
Freq: 1 time a day
Single dose: 500 mg
Salimzadeh Iran 2018 T: NA T: 39/NA/39 Garlic extract Placebo WOMAC
C: NA C: 37/NA/37 Length of Intervention: 12 weeks
Freq: 2 times a day
Single dose: 500 mg
Hancke India 2019 T: 55.3 (8.2) T: 35/4/31 Andrographis paniculata extract Placebo WOMAC, SF-36
C: 55.7 (7.7) C: 36/9/27 Length of Intervention: 84 days
Freq: 2 times a day
Single dose: 300 mg
Henrotin Belgium 2019 T: 60.9 (9.78) T: 49/10/39 Curcuma extract Placebo KOOS
C: 63.3 (7.69) C: 45/11/34 Length of Intervention: 3 months
Freq: 2 times a day
Single dose: 3 caps
Alazadeh Iran 2020 T: NA T: 33/NA/33 Fennel extract Placebo WOMAC, VAS
C: NA C: 33/NA/33 Length of Intervention: 2 weeks
Freq: 2 times a day
Single dose: 400 mg
Ha Korea 2021 T: 60.57 (8.93) T: 53/7/46 Chrysanthemum zawadskii extract Placebo WOMAC, VAS, SF-36
C: 59.63 (8.05) C: 57/6/51 Length of Intervention: 12 weeks
Freq: 1 time a day
Single dose: 600 mg
Singhal India 2021 T: 53.1 (10.9) T: 73/20/53 Curcuma extract Usual treatment WOMAC
C: 50.8 (9.9) C: 71/17/54 Length of Intervention: 6 weeks
Freq: 2 times a day
Single dose: 500 mg
Henrotin Belgium 2022 T: 55.69 (1.25) T: 64/21/43 Rubus idaeus leaf extract Placebo WOMAC, VAS, SF-36
C: 52.93 (1.39) C: 68/25/43 Length of Intervention: 12 weeks
Freq: 1 time a day
Single dose: 400 mg
Huseini Iran 2022 T: 59.6 (9.1) T: 58/16/42 Nigella sativa extract Placebo WOMAC, VAS
C: 63.3 (8.6) C: 58/13/45 Length of Intervention: 1 month
Freq: 3 times a day
Single dose: 5 mL
Kim Korea 2023 T: 42.3 (12.6) T: 40/14/26 Zisu extract Placebo WOMAC, VAS
C: 34.5 (14.5) C: 40/14/26 Length of Intervention: 8 weeks
Freq: 2 times a day
Single dose: 700 mg
Nash UNITED KINGDOM 2023 T: NA T: 31/13/18 Cucumis sativus extract Placebo WOMAC, VAS, LPFI
C: NA C: 46/21/25 Length of Intervention: 180 days
Freq: 2 times a day
Single dose: 50 mg
Navid Iran 2023 T: 57.33 (8.85) T: 52/23/29 Jadwar extract Placebo WOMAC, VAS
C: 59.43 (7.88) C: 52/24/28 Length of Intervention: 4 weeks
Freq: 2 times a day
Single dose: 500 mg
Taheri Iran 2023 T: 54.13 (7.53) T: 43/10/33 Squill oxymel extract Placebo VAS, KOOS
C: 5508.8 (7.12) C: 45/8/37 Length of Intervention: 8 weeks
Freq: 1 time a day
Single dose: 10 mL

CON: control group with Placebo or Usual treatment, T: experimental group, C: control group, WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index, VAS: Visual Analogue Scale, SF-36: Short Form 36 Health Survey, KOOS: Knee injury and Osteoarthritis Outcome Score, LPFI: Lequesne抯 Pain-Function Index, JOA: Japanese Orthopaedic Association Score.

We used Grade to evaluate the evidence level of three indicators. Since there was no closed loop situation for all indicators, all inconsistent dimensions were downgraded. Specific details are presented. Specific details will be presented in Supplementary Table S1.

 3.3 Characteristics of included studies

A total of 36 RCTs involving 3,285 patients diagnosed with KOA were included in this study. The interventions in the control group included Zingiber officinale Roscoe [Zingiberaceae; Zingiberis rhizoma] extract (3 studies) (Altman and Marcussen, 2001; Wigler et al., 2003; Zakeri et al., 2011), Ananas comosus (L.) Merr. [Bromeliaceae; Ananasis caulis] extract (1 study) (Brien et al., 2006), Boswellia serrata Roxb. ex Colebr. [Burseraceae; Olibanum indicum] extract (1 study) (Sontakke et al., 2007), Passiflora edulis Sims [Passifloraceae; Passiflorae edulis pericarpium] extract (1 study) (Farid et al., 2010), Derris scandens (Roxb.) Benth. [Fabaceae; Derridis scandentis caulis] extract (1 study) (Kuptniratsaikul et al., 2011), Curcuma longa L. [Zingiberaceae; Curcumae longae rhizoma] extract (8 studies) (Henrotin et al., 2019; Kuptniratsaikul et al., 2014; Madhu et al., 2013; Panahi et al., 2014; Panda et al., 2018; Pinsornsak and Niempoog, 2012; Singhal et al., 2021; Srivastava et al., 2016), Sesamum indicum L. [Pedaliaceae; Sesami semen] extract (1 study) (Eftekhar Sadat et al., 2013), Prunus cerasus L. [Rosaceae; Pruni cerasi fructus] extract (1 study) (Schumacher et al., 2013), Olea europaea L. [Oleaceae; Oleae folium] extract (1 study) (Takeda et al., 2013), Punica granatum L. [Lythraceae; Granati pericarpium] extract (1 study) (Ghoochani et al., 2016), Elaeagnus angustifolia L. [Elaeagnaceae; Elaeagni angustifoliae fructus] extract(1 study) (Panahi et al., 2016), Withania somnifera (L.) Dunal [Solanaceae; Withaniae radix] extract (1 study) (Ramakanth et al., 2016), Argania spinosa (L.) Skeels [Sapotaceae; Arganiae oleum] extract (1 study) (Essouiri et al., 2017), Camellia sinensis (L.) Kuntze [Theaceae; Theae folium] extract (1 study) (Hashempur et al., 2018), Psidium guajava L. [Myrtaceae; Psidii guajavae folium] extract (1 study) (Kakuo et al., 2018), Momordica charantia L. [Cucurbitaceae; Momordicae fructus] extract (1 study) (May et al., 2018), Cucumis sativus L. [Cucurbitaceae; Cucumeris sativi fructus] extract (2 studies) (Nash et al., 2018; Nash et al., 2023), Allium sativum L. [Amaryllidaceae; Allii sativi bulbus] extract (1 study) (Salimzadeh et al., 2018), Andrographis paniculata (Burm.f.) Nees [Acanthaceae; Andrographidis herba] extract (1 study) (Hancke et al., 2019), Foeniculum vulgare Mill. [Apiaceae; Foeniculi fructus] extract (1 study) (Alazadeh et al., 2020), Chrysanthemum zawadskii var. latilobum [Asteraceae; Chrysanthemi flos] extract (1 study) (Ha et al., 2021), Rubus idaeus L. [Rosaceae; Rubi idaei folium] extract (1 study) (Henrotin et al., 2022), Nigella sativa L. [Ranunculaceae; Nigellae semen] extract (1 study) (Huseini et al., 2022), erilla frutescens (L.) Britton [Lamiaceae; Perillae folium] extract (1 study) (Kim et al., 2023), Delphinium denudatum Wall. ex Hook. f. and Thomson [Ranunculaceae; Delphinii radix] extractt (1 study) (Navid et al., 2023), and Drimia maritima (L.) Stearn [Asparagaceae; Scillae bulbus] extract (1 study) (Taheri et al., 2023). Twenty-eight studies reported WOMAC as the outcome measure, 21 studies reported VAS, 5 studies reported KOOS, and 5 studies reported SF-36 as outcome measures. Of these, 28 studies were conducted in Asia, 2 in the Americas, 5 in Europe, and 1 in Africa. Since the age and gender distribution in the included studies are relatively consistent, transitivity is considered to be good. The characteristics of the included studies are summarized in Table 2. The pharmacopoeia and detailed characteristics of each plant extract are shown in Table 3.

League table on Pain Score.

CS extract Ashwagandha extract AP extract Jadwar extract PFP extract Curcuma extract Sesame extract MC extract NS extract Fennel extract Ginger extract Pomegranate extract GL extract Pineapple extract
CS extract 2.87 (−1.76,7.50) 4.85 (0.31,9.39) 4.99 (0.46,9.52) 5.01 (0.43,9.59) 5.55 (2.66,8.45) 5.50 (0.94,10.07) 5.59 (1.06,10.13) 5.79 (1.27,10.31) 5.87 (1.33,10.40) 5.99 (2.50,9.49) 6.13 (1.57,10.68) 6.18 (1.64,10.72) 6.36 (1.80,10.92)
−2.87 (−7.50,1.76) Ashwagandha extract 1.98 (−3.13,7.09) 2.12 (−2.98,7.22) 2.14 (−3.00,7.28) 2.68 (−1.30,6.66) 2.63 (−2.98,8.25) 2.72 (−2.38,7.82) 2.92 (−2.17,8.01) 3.00 (−2.11,8.10) 3.12 (−1.08,7.33) 3.26 (−1.86,8.37) 3.31 (−1.80,8.42) 3.49 (−1.64,8.61)
−4.85 (−9.39,−0.31) −1.98 (−7.09,3.13) AP extract 0.14 (−4.87,5.16) 0.16 (−4.89,5.22) 0.70 (−3.17,4.57) 0.66 (−4.88,6.20) 0.75 (−4.27,5.77) 0.94 (−4.07,5.95) 1.02 (−4.00,6.04) 1.15 (−2.96,5.25) 1.28 (−3.76,6.32) 1.33 (−3.69,6.36) 1.51 (−3.53,6.55)
−4.99 (−9.52,−0.46) −2.12 (−7.22,2.98) −0.14 (−5.16,4.87) Jadwar extract 0.02 (−5.02,5.07) 0.56 (−3.29,4.42) 0.52 (−5.01,6.04) 0.61 (−4.40,5.61) 0.80 (−4.20,5.80) 0.88 (−4.13,5.88) 1.00 (−3.09,5.09) 1.14 (−3.89,6.16) 1.19 (−3.82,6.20) 1.37 (−3.66,6.40)
−5.01 (−9.59,−0.43) −2.14 (−7.28,3.00) −0.16 (−5.22,4.89) −0.02 (−5.07,5.02) PFP extract 0.54 (−3.37,4.45) 0.49 (−5.07,6.06) 0.58 (−4.47,5.63) 0.78 (−4.26,5.82) 0.86 (−4.20,5.91) 0.98 (−3.16,5.13) 1.12 (−3.95,6.18) 1.17 (−3.89,6.23) 1.35 (−3.73,6.42)
−5.55 (−8.45,−2.66) −2.68 (−6.66,1.30) −0.70 (−4.57,3.17) −0.56 (−4.42,3.29) −0.54 (−4.45,3.37) Curcuma extract −0.05 (−4.08,3.99) 0.04 (−3.81,3.90) 0.24 (−3.61,4.09) 0.32 (−3.54,4.18) 0.44 (−2.12,3.00) 0.58 (−3.31,4.46) 0.63 (−3.24,4.50) 0.81 (−3.08,4.70)
−5.50 (−10.07,−0.94) −2.63 (−8.25,2.98) −0.66 (−6.20,4.88) −0.52 (−6.04,5.01) −0.49 (−6.06,5.07) 0.05 (−3.99,4.08) Sesame extract 0.09 (−5.44,5.62) 0.29 (−5.24,5.81) 0.36 (−5.17,5.89) 0.49 (−4.23,5.20) 0.62 (−4.92,6.17) 0.68 (−4.86,6.21) 0.85 (−4.70,6.41)
−5.59 (−10.13,−1.06) −2.72 (−7.82,2.38) −0.75 (−5.77,4.27) −0.61 (−5.61,4.40) −0.58 (−5.63,4.47) −0.04 (−3.90,3.81) −0.09 (−5.62,5.44) MC extract 0.20 (−4.80,5.20) 0.27 (−4.74,5.28) 0.40 (−3.69,4.49) 0.53 (−4.50,5.56) 0.59 (−4.43,5.60) 0.76 (−4.27,5.80)
−5.79 (−10.31,−1.27) −2.92 (−8.01,2.17) −0.94 (−5.95,4.07) −0.80 (−5.80,4.20) −0.78 (−5.82,4.26) −0.24 (−4.09,3.61) −0.29 (−5.81,5.24) −0.20 (−5.20,4.80) NS extract 0.08 (−4.93,5.08) 0.20 (−3.88,4.29) 0.34 (−4.68,5.36) 0.39 (−4.62,5.40) 0.57 (−4.46,5.59)
−5.87 (−10.40,−1.33) −3.00 (−8.10,2.11) −1.02 (−6.04,4.00) −0.88 (−5.88,4.13) −0.86 (−5.91,4.20) −0.32 (−4.18,3.54) −0.36 (−5.89,5.17) −0.27 (−5.28,4.74) −0.08 (−5.08,4.93) Fennel extract 0.13 (−3.97,4.22) 0.26 (−4.77,5.29) 0.31 (−4.70,5.33) 0.49 (−4.54,5.53)
−5.99 (−9.49,−2.50) −3.12 (−7.33,1.08) −1.15 (−5.25,2.96) −1.00 (−5.09,3.09) −0.98 (−5.13,3.16) −0.44 (−3.00,2.12) −0.49 (−5.20,4.23) −0.40 (−4.49,3.69) −0.20 (−4.29,3.88) −0.13 (−4.22,3.97) Ginger extract 0.13 (−3.98,4.25) 0.19 (−3.91,4.29) 0.37 (−3.76,4.49)
−6.13 (−10.68,−1.57) −3.26 (−8.37,1.86) −1.28 (−6.32,3.76) −1.14 (−6.16,3.89) −1.12 (−6.18,3.95) −0.58 (−4.46,3.31) −0.62 (−6.17,4.92) −0.53 (−5.56,4.50) −0.34 (−5.36,4.68) −0.26 (−5.29,4.77) −0.13 (−4.25,3.98) Pomegranate extract 0.05 (−4.98,5.09) 0.23 (−4.82,5.28)
−6.18 (−10.72,−1.64) −3.31 (−8.42,1.80) −1.33 (−6.36,3.69) −1.19 (−6.20,3.82) −1.17 (−6.23,3.89) −0.63 (−4.50,3.24) −0.68 (−6.21,4.86) −0.59 (−5.60,4.43) −0.39 (−5.40,4.62) −0.31 (−5.33,4.70) −0.19 (−4.29,3.91) −0.05 (−5.09,4.98) GL extract 0.18 (−4.86,5.22)
−6.36 (−10.92,−1.80) −3.49 (−8.61,1.64) −1.51 (−6.55,3.53) −1.37 (−6.40,3.66) −1.35 (−6.42,3.73) −0.81 (−4.70,3.08) −0.85 (−6.41,4.70) −0.76 (−5.80,4.27) −0.57 (−5.59,4.46) −0.49 (−5.53,4.54) −0.37 (−4.49,3.76) −0.23 (−5.28,4.82) −0.18 (−5.22,4.86) Pineapple extract
−6.40 (−10.96,−1.85) −3.53 (−9.14,2.07) −1.56 (−7.08,3.97) −1.42 (−6.93,4.10) −1.39 (−6.95,4.16) −0.85 (−4.88,3.17) −0.90 (−5.92,4.12) −0.81 (−6.33,4.71) −0.61 (−6.12,4.90) −0.54 (−6.06,4.98) −0.41 (−5.11,4.29) −0.28 (−5.81,5.26) −0.22 (−5.75,5.30) −0.05 (−5.59,5.49)
−6.34 (−10.87,−1.81) −3.47 (−8.57,1.62) −1.50 (−6.51,3.52) −1.35 (−6.36,3.65) −1.33 (−6.38,3.71) −0.79 (−4.65,3.06) −0.84 (−6.36,4.69) −0.75 (−5.76,4.26) −0.55 (−5.55,4.45) −0.48 (−5.48,4.53) −0.35 (−4.44,3.74) −0.22 (−5.24,4.81) −0.16 (−5.17,4.85) 0.02 (−5.02,5.05)
−6.38 (−10.90,−1.85) −3.51 (−8.60,1.59) −1.53 (−6.54,3.48) −1.39 (−6.38,3.61) −1.37 (−6.41,3.68) −0.83 (−4.67,3.02) −0.87 (−6.39,4.65) −0.78 (−5.78,4.22) −0.59 (−5.58,4.41) −0.51 (−5.51,4.49) −0.38 (−4.47,3.70) −0.25 (−5.27,4.77) −0.20 (−5.20,4.81) −0.02 (−5.04,5.01)
−6.46 (−11.03,−1.89) −3.59 (−9.20,2.03) −1.61 (−7.15,3.93) −1.47 (−7.00,4.06) −1.45 (−7.01,4.12) −0.91 (−4.95,3.13) −0.95 (−5.99,4.08) −0.86 (−6.39,4.67) −0.67 (−6.19,4.86) −0.59 (−6.12,4.94) −0.46 (−5.18,4.25) −0.33 (−5.88,5.22) −0.28 (−5.81,5.26) −0.10 (−5.65,5.46)
−6.44 (−10.99,−1.90) −3.57 (−9.17,2.02) −1.60 (−7.11,3.92) −1.45 (−6.96,4.05) −1.43 (−6.98,4.11) −0.89 (−4.90,3.12) −0.94 (−5.95,4.07) −0.85 (−6.36,4.66) −0.65 (−6.16,4.85) −0.58 (−6.09,4.93) −0.45 (−5.14,4.24) −0.32 (−5.84,5.21) −0.26 (−5.78,5.25) −0.08 (−5.62,5.45)
−6.52 (−11.06,−1.97) −3.65 (−8.76,1.46) −1.67 (−6.70,3.36) −1.53 (−6.54,3.49) −1.51 (−6.57,3.55) −0.97 (−4.84,2.91) −1.01 (−6.55,4.53) −0.92 (−5.94,4.10) −0.73 (−5.74,4.28) −0.65 (−5.67,4.37) −0.52 (−4.63,3.58) −0.39 (−5.43,4.65) −0.34 (−5.36,4.69) −0.16 (−5.20,4.89)
−6.53 (−11.09,−1.98) −3.66 (−9.26,1.94) −1.69 (−7.21,3.84) −1.54 (−7.06,3.97) −1.52 (−7.08,4.03) −0.98 (−5.01,3.04) −1.03 (−6.05,3.99) −0.94 (−6.46,4.58) −0.74 (−6.25,4.77) −0.67 (−6.19,4.85) −0.54 (−5.24,4.16) −0.41 (−5.94,5.13) −0.35 (−5.88,5.17) −0.17 (−5.72,5.37)
−6.55 (−11.07,−2.03) −3.68 (−8.77,1.41) −1.70 (−6.71,3.30) −1.56 (−6.55,3.43) −1.54 (−6.58,3.50) −1.00 (−4.84,2.84) −1.04 (−6.56,4.47) −0.96 (−5.95,4.04) −0.76 (−5.75,4.23) −0.68 (−5.68,4.32) −0.56 (−4.64,3.52) −0.42 (−5.44,4.59) −0.37 (−5.37,4.63) −0.19 (−5.21,4.83)
−6.44 (−9.31,−3.58) −3.57 (−7.91,0.77) −1.60 (−5.84,2.65) −1.45 (−5.68,2.77) −1.43 (−5.71,2.85) −0.89 (−2.80,1.01) −0.94 (−4.50,2.62) −0.85 (−5.08,3.38) −0.65 (−4.88,3.57) −0.58 (−4.81,3.66) −0.45 (−3.54,2.64) −0.32 (−4.57,3.94) −0.26 (−4.50,3.98) −0.08 (−4.35,4.18)
−6.54 (−11.06,−2.02) −3.67 (−8.76,1.42) −1.69 (−6.70,3.31) −1.55 (−6.55,3.44) −1.53 (−6.57,3.51) −0.99 (−4.84,2.86) −1.04 (−6.56,4.48) −0.95 (−5.95,4.05) −0.75 (−5.74,4.24) −0.67 (−5.68,4.33) −0.55 (−4.63,3.53) −0.42 (−5.43,4.60) −0.36 (−5.37,4.64) −0.18 (−5.21,4.84)
−6.61 (−11.13,−2.08) −3.74 (−8.83,1.36) −1.76 (−6.77,3.25) −1.62 (−6.62,3.38) −1.60 (−6.64,3.45) −1.06 (−4.91,2.79) −1.10 (−6.63,4.42) −1.01 (−6.02,3.99) −0.82 (−5.81,4.18) −0.74 (−5.75,4.26) −0.62 (−4.70,3.47) −0.48 (−5.50,4.54) −0.43 (−5.44,4.58) −0.25 (−5.28,4.78)
−6.68 (−11.21,−2.15) −3.81 (−8.91,1.29) −1.83 (−6.85,3.18) −1.69 (−6.69,3.31) −1.67 (−6.71,3.38) −1.13 (−4.98,2.73) −1.17 (−6.70,4.35) −1.08 (−6.09,3.92) −0.89 (−5.89,4.11) −0.81 (−5.82,4.20) −0.68 (−4.77,3.40) −0.55 (−5.58,4.47) −0.50 (−5.51,4.51) −0.32 (−5.35,4.71)
−6.80 (−11.37,−2.22) −3.93 (−9.07,1.21) −1.95 (−7.01,3.11) −1.81 (−6.85,3.23) −1.79 (−6.87,3.30) −1.25 (−5.15,2.66) −1.29 (−6.86,4.27) −1.20 (−6.25,3.84) −1.01 (−6.05,4.03) −0.93 (−5.98,4.12) −0.80 (−4.94,3.34) −0.67 (−5.74,4.39) −0.62 (−5.67,4.44) −0.44 (−5.51,4.63)
−6.65 (−9.48,−3.83) −3.78 (−7.45,−0.11) −1.81 (−5.36,1.75) −1.66 (−5.20,1.87) −1.64 (−5.24,1.96) −1.10 (−2.63,0.43) −1.15 (−5.39,3.10) −1.06 (−4.60,2.48) −0.86 (−4.39,2.67) −0.79 (−4.33,2.76) −0.66 (−2.71,1.39) −0.53 (−4.10,3.04) −0.47 (−4.02,3.08) −0.29 (−3.87,3.28)
BS extract Zisu extract Argan extract GT extract DSB extracts Cherry extract EA extract RIL extract Usual treatment CZ extract SO extract Garlic extract OL extract Placebo
6.40 (1.85,10.96) 6.34 (1.81,10.87) 6.38 (1.85,10.90) 6.46 (1.89,11.03) 6.44 (1.90,10.99) 6.52 (1.97,11.06) 6.53 (1.98,11.09) 6.55 (2.03,11.07) 6.44 (3.58,9.31) 6.54 (2.02,11.06) 6.61 (2.08,11.13) 6.68 (2.15,11.21) 6.80 (2.22,11.37) 6.65 (3.83,9.48)
3.53 (−2.07,9.14) 3.47 (−1.62,8.57) 3.51 (−1.59,8.60) 3.59 (−2.03,9.20) 3.57 (−2.02,9.17) 3.65 (−1.46,8.76) 3.66 (−1.94,9.26) 3.68 (−1.41,8.77) 3.57 (−0.77,7.91) 3.67 (−1.42,8.76) 3.74 (−1.36,8.83) 3.81 (−1.29,8.91) 3.93 (−1.21,9.07) 3.78 (0.11,7.45)
1.56 (−3.97,7.08) 1.50 (−3.52,6.51) 1.53 (−3.48,6.54) 1.61 (−3.93,7.15) 1.60 (−3.92,7.11) 1.67 (−3.36,6.70) 1.69 (−3.84,7.21) 1.70 (−3.30,6.71) 1.60 (−2.65,5.84) 1.69 (−3.31,6.70) 1.76 (−3.25,6.77) 1.83 (−3.18,6.85) 1.95 (−3.11,7.01) 1.81 (−1.75,5.36)
1.42 (−4.10,6.93) 1.35 (−3.65,6.36) 1.39 (−3.61,6.38) 1.47 (−4.06,7.00) 1.45 (−4.05,6.96) 1.53 (−3.49,6.54) 1.54 (−3.97,7.06) 1.56 (−3.43,6.55) 1.45 (−2.77,5.68) 1.55 (−3.44,6.55) 1.62 (−3.38,6.62) 1.69 (−3.31,6.69) 1.81 (−3.23,6.85) 1.66 (−1.87,5.20)
1.39 (−4.16,6.95) 1.33 (−3.71,6.38) 1.37 (−3.68,6.41) 1.45 (−4.12,7.01) 1.43 (−4.11,6.98) 1.51 (−3.55,6.57) 1.52 (−4.03,7.08) 1.54 (−3.50,6.58) 1.43 (−2.85,5.71) 1.53 (−3.51,6.57) 1.60 (−3.45,6.64) 1.67 (−3.38,6.71) 1.79 (−3.30,6.87) 1.64 (−1.96,5.24)
0.85 (−3.17,4.88) 0.79 (−3.06,4.65) 0.83 (−3.02,4.67) 0.91 (−3.13,4.95) 0.89 (−3.12,4.90) 0.97 (−2.91,4.84) 0.98 (−3.04,5.01) 1.00 (−2.84,4.84) 0.89 (−1.01,2.80) 0.99 (−2.86,4.84) 1.06 (−2.79,4.91) 1.13 (−2.73,4.98) 1.25 (−2.66,5.15) 1.10 (−0.43,2.63)
0.90 (−4.12,5.92) 0.84 (−4.69,6.36) 0.87 (−4.65,6.39) 0.95 (−4.08,5.99) 0.94 (−4.07,5.95) 1.01 (−4.53,6.55) 1.03 (−3.99,6.05) 1.04 (−4.47,6.56) 0.94 (−2.62,4.50) 1.04 (−4.48,6.56) 1.10 (−4.42,6.63) 1.17 (−4.35,6.70) 1.29 (−4.27,6.86) 1.15 (−3.10,5.39)
0.81 (−4.71,6.33) 0.75 (−4.26,5.76) 0.78 (−4.22,5.78) 0.86 (−4.67,6.39) 0.85 (−4.66,6.36) 0.92 (−4.10,5.94) 0.94 (−4.58,6.46) 0.96 (−4.04,5.95) 0.85 (−3.38,5.08) 0.95 (−4.05,5.95) 1.01 (−3.99,6.02) 1.08 (−3.92,6.09) 1.20 (−3.84,6.25) 1.06 (−2.48,4.60)
0.61 (−4.90,6.12) 0.55 (−4.45,5.55) 0.59 (−4.41,5.58) 0.67 (−4.86,6.19) 0.65 (−4.85,6.16) 0.73 (−4.28,5.74) 0.74 (−4.77,6.25) 0.76 (−4.23,5.75) 0.65 (−3.57,4.88) 0.75 (−4.24,5.74) 0.82 (−4.18,5.81) 0.89 (−4.11,5.89) 1.01 (−4.03,6.05) 0.86 (−2.67,4.39)
0.54 (−4.98,6.06) 0.48 (−4.53,5.48) 0.51 (−4.49,5.51) 0.59 (−4.94,6.12) 0.58 (−4.93,6.09) 0.65 (−4.37,5.67) 0.67 (−4.85,6.19) 0.68 (−4.32,5.68) 0.58 (−3.66,4.81) 0.67 (−4.33,5.68) 0.74 (−4.26,5.75) 0.81 (−4.20,5.82) 0.93 (−4.12,5.98) 0.79 (−2.76,4.33)
0.41 (−4.29,5.11) 0.35 (−3.74,4.44) 0.38 (−3.70,4.47) 0.46 (−4.25,5.18) 0.45 (−4.24,5.14) 0.52 (−3.58,4.63) 0.54 (−4.16,5.24) 0.56 (−3.52,4.64) 0.45 (−2.64,3.54) 0.55 (−3.53,4.63) 0.62 (−3.47,4.70) 0.68 (−3.40,4.77) 0.80 (−3.34,4.94) 0.66 (−1.39,2.71)
0.28 (−5.26,5.81) 0.22 (−4.81,5.24) 0.25 (−4.77,5.27) 0.33 (−5.22,5.88) 0.32 (−5.21,5.84) 0.39 (−4.65,5.43) 0.41 (−5.13,5.94) 0.42 (−4.59,5.44) 0.32 (−3.94,4.57) 0.42 (−4.60,5.43) 0.48 (−4.54,5.50) 0.55 (−4.47,5.58) 0.67 (−4.39,5.74) 0.53 (−3.04,4.10)
0.22 (−5.30,5.75) 0.16 (−4.85,5.17) 0.20 (−4.81,5.20) 0.28 (−5.26,5.81) 0.26 (−5.25,5.78) 0.34 (−4.69,5.36) 0.35 (−5.17,5.88) 0.37 (−4.63,5.37) 0.26 (−3.98,4.50) 0.36 (−4.64,5.37) 0.43 (−4.58,5.44) 0.50 (−4.51,5.51) 0.62 (−4.44,5.67) 0.47 (−3.08,4.02)
0.05 (−5.49,5.59) −0.02 (−5.05,5.02) 0.02 (−5.01,5.04) 0.10 (−5.46,5.65) 0.08 (−5.45,5.62) 0.16 (−4.89,5.20) 0.17 (−5.37,5.72) 0.19 (−4.83,5.21) 0.08 (−4.18,4.35) 0.18 (−4.84,5.21) 0.25 (−4.78,5.28) 0.32 (−4.71,5.35) 0.44 (−4.63,5.51) 0.29 (−3.28,3.87)
BS extract −0.06 (−5.58,5.45) −0.03 (−5.54,5.48) 0.05 (−4.97,5.08) 0.04 (−4.96,5.04) 0.11 (−5.41,5.64) 0.13 (−4.88,5.14) 0.14 (−5.36,5.65) 0.04 (−3.50,3.58) 0.14 (−5.37,5.65) 0.20 (−5.31,5.72) 0.27 (−5.24,5.79) 0.39 (−5.16,5.95) 0.25 (−3.98,4.48)
0.06 (−5.45,5.58) Zisu extract 0.03 (−4.97,5.03) 0.11 (−5.41,5.64) 0.10 (−5.41,5.61) 0.17 (−4.84,5.19) 0.19 (−5.33,5.71) 0.21 (−4.79,5.20) 0.10 (−4.13,4.33) 0.20 (−4.80,5.19) 0.27 (−4.73,5.27) 0.33 (−4.67,5.34) 0.45 (−4.59,5.50) 0.31 (−3.23,3.85)
0.03 (−5.48,5.54) −0.03 (−5.03,4.97) Argan extract 0.08 (−5.44,5.61) 0.07 (−5.44,5.57) 0.14 (−4.87,5.15) 0.16 (−5.35,5.67) 0.17 (−4.82,5.16) 0.07 (−4.15,4.29) 0.17 (−4.83,5.16) 0.23 (−4.76,5.23) 0.30 (−4.70,5.30) 0.42 (−4.62,5.46) 0.28 (−3.25,3.81)
−0.05 (−5.08,4.97) −0.11 (−5.64,5.41) −0.08 (−5.61,5.44) GT extract −0.01 (−5.03,5.00) 0.06 (−5.48,5.60) 0.08 (−4.95,5.10) 0.09 (−5.43,5.61) −0.01 (−3.58,3.55) 0.08 (−5.44,5.61) 0.15 (−5.37,5.68) 0.22 (−5.31,5.75) 0.34 (−5.23,5.91) 0.20 (−4.05,4.44)
−0.04 (−5.04,4.96) −0.10 (−5.61,5.41) −0.07 (−5.57,5.44) 0.01 (−5.00,5.03) DSB extracts 0.07 (−5.45,5.59) 0.09 (−4.91,5.09) 0.11 (−5.39,5.60) 0.00 (−3.53,3.53) 0.10 (−5.40,5.60) 0.17 (−5.34,5.67) 0.23 (−5.27,5.74) 0.35 (−5.19,5.90) 0.21 (−4.01,4.43)
−0.11 (−5.64,5.41) −0.17 (−5.19,4.84) −0.14 (−5.15,4.87) −0.06 (−5.60,5.48) −0.07 (−5.59,5.45) Cherry extract 0.02 (−5.51,5.54) 0.03 (−4.98,5.04) −0.07 (−4.32,4.17) 0.02 (−4.99,5.03) 0.09 (−4.92,5.10) 0.16 (−4.86,5.18) 0.28 (−4.78,5.34) 0.14 (−3.42,3.69)
−0.13 (−5.14,4.88) −0.19 (−5.71,5.33) −0.16 (−5.67,5.35) −0.08 (−5.10,4.95) −0.09 (−5.09,4.91) −0.02 (−5.54,5.51) EA extract 0.02 (−5.49,5.52) −0.09 (−3.63,3.45) 0.01 (−5.50,5.52) 0.08 (−5.44,5.59) 0.14 (−5.37,5.66) 0.26 (−5.29,5.82) 0.12 (−4.11,4.35)
−0.14 (−5.65,5.36) −0.21 (−5.20,4.79) −0.17 (−5.16,4.82) −0.09 (−5.61,5.43) −0.11 (−5.60,5.39) −0.03 (−5.04,4.98) −0.02 (−5.52,5.49) RIL extract −0.11 (−4.32,4.11) −0.01 (−5.00,4.98) 0.06 (−4.93,5.05) 0.13 (−4.87,5.12) 0.25 (−4.79,5.28) 0.10 (−3.42,3.63)
−0.04 (−3.58,3.50) −0.10 (−4.33,4.13) −0.07 (−4.29,4.15) 0.01 (−3.55,3.58) −0.00 (−3.53,3.53) 0.07 (−4.17,4.32) 0.09 (−3.45,3.63) 0.11 (−4.11,4.32) Usual treatment 0.10 (−4.12,4.32) 0.17 (−4.06,4.39) 0.23 (−3.99,4.46) 0.35 (−3.92,4.63) 0.21 (−2.10,2.53)
−0.14 (−5.65,5.37) −0.20 (−5.19,4.80) −0.17 (−5.16,4.83) −0.08 (−5.61,5.44) −0.10 (−5.60,5.40) −0.02 (−5.03,4.99) −0.01 (−5.52,5.50) 0.01 (−4.98,5.00) −0.10 (−4.32,4.12) CZ extract 0.07 (−4.93,5.06) 0.14 (−4.86,5.13) 0.26 (−4.78,5.29) 0.11 (−3.42,3.64)
−0.20 (−5.72,5.31) −0.27 (−5.27,4.73) −0.23 (−5.23,4.76) −0.15 (−5.68,5.37) −0.17 (−5.67,5.34) −0.09 (−5.10,4.92) −0.08 (−5.59,5.44) −0.06 (−5.05,4.93) −0.17 (−4.39,4.06) −0.07 (−5.06,4.93) SO extract 0.07 (−4.93,5.07) 0.19 (−4.85,5.23) 0.04 (−3.49,3.58)
−0.27 (−5.79,5.24) −0.33 (−5.34,4.67) −0.30 (−5.30,4.70) −0.22 (−5.75,5.31) −0.23 (−5.74,5.27) −0.16 (−5.18,4.86) −0.14 (−5.66,5.37) −0.13 (−5.12,4.87) −0.23 (−4.46,3.99) −0.14 (−5.13,4.86) −0.07 (−5.07,4.93) Garlic extract 0.12 (−4.92,5.16) −0.02 (−3.56,3.51)
−0.39 (−5.95,5.16) −0.45 (−5.50,4.59) −0.42 (−5.46,4.62) −0.34 (−5.91,5.23) −0.35 (−5.90,5.19) −0.28 (−5.34,4.78) −0.26 (−5.82,5.29) −0.25 (−5.28,4.79) −0.35 (−4.63,3.92) −0.26 (−5.29,4.78) −0.19 (−5.23,4.85) −0.12 (−5.16,4.92) OL extract −0.14 (−3.74,3.45)
−0.25 (−4.48,3.98) −0.31 (−3.85,3.23) −0.28 (−3.81,3.25) −0.20 (−4.44,4.05) −0.21 (−4.43,4.01) −0.14 (−3.69,3.42) −0.12 (−4.35,4.11) −0.10 (−3.63,3.42) −0.21 (−2.53,2.10) −0.11 (−3.64,3.42) −0.04 (−3.58,3.49) 0.02 (−3.51,3.56) 0.14 (−3.45,3.74) Placebo

Characteristics of extracts included in the literature.

Plant species Pharmacopoeial status Extract details (As reported in study) Metabolites analyzed/quantified in original study Reference
Foeniculum vulgare Mill JP, EP (fruit/seed) 200 mg dried extract per capsule (from 7 g seeds), 70% ethanol maceration, 4 capsules/day Total flavonoids 0.81 mg/g (quercetin equivalent) Alazadeh et al., 2020
Zingiber officinale Roscoe (Ginger) JP, USP, EP, BP 255 mg EV.EXT77 capsule twice daily (total 510 mg/day), extracted from 2.5–4 g dried ginger + 0.5–1.5 g Alpinia galanga, standardized to gingerols Gingerols identified; no quantification of individual gingerols or total gingerol content reported Altman and Marcussen, 2001
Delphinium denudatum Wall. (Jadwar) No pharmacopoeial monograph identified Root powder extract Delphinine, stahisagrine, delphocurarine, condelphine, denudatin, isotalatizidine, quercetin Navid et al., 2023
Ananas comosus (Bromelain) USP 800 mg/day bromelain (two 200 mg tablets bid), crude aqueous pineapple stem extract, standardized enzyme activity (FIP units). No quantification of individual enzymes or proteolytic activity reported. Brien et al., 2006
Sesamum indicum L. (Sesame) USP, EP (seeds/oil) Ground sesame seed powder, 40 g/day orally for 2 months Lignans (e.g., sesamin, sesamolin), vitamin E, unsaturated fatty acids (not quantified) Eftekhar Sadat et al., 2013
Argania spinosa (Argan) EP (oil) Culinary argan oil, 30 mL/day for 8 weeks Tocopherols (e.g., γ-tocopherol 75%), phytosterols, squalene, unsaturated fatty acids (reported from prior compositional analysis) Essouiri et al., 2017
Passiflora edulis Sims (Passion fruit peel) No pharmacopoeial monograph identified 150 mg/day PFP extract capsule, flavonoid-rich (anthocyanins, quercetin, luteolin, cyanidin-3-O-glucoside) Flavonoids identified by HPLC; no quantification of individual flavonoids or total flavonoid content. Farid et al., 2010
Punica granatum L. (Pomegranate) EP (peel); juice not monographed Pomegranate juice, 200 mL/day for 6 weeks Polyphenols (punicalagin, ellagic acid), anthocyanins (not quantified in this study) Ghoochani et al., 2016
Chrysanthemum zawadskii var. latilobum Chinese Pharmacopoeia (Chrysanthemum morifolium); not in JP/USP/EP/BP Ethanol extract from stems and leaves Linarin, other flavonoids and phenols Ha et al., 2021
Andrographis paniculata Nees Chinese/Indian Pharmacopoeia; not in JP/USP/EP/BP 300 or 600 mg/day ParActin®, 50% andrographolide Andrographolide quantified; 14-deoxyandrographolide & neoandrographolide also detected Hancke et al., 2019
Camellia sinensis (Green tea) JP, USP, EP, BP 1500 mg/day green tea tablet, 33.97% EGCG, 50.65 mg pyrogallol EGCG and pyrogallol quantified by HPLC Hashempur et al., 2018
Rubus idaeus (Raspberry) No pharmacopoeial monograph identified Ethanolic leaf extract Sanguiine H6 (a polyphenol), other polyphenols Henrotin et al., 2022
Curcuma longa L. (Turmeric) JP, EP, USP (rhizome) Bio-optimized Curcuma longa extract (Flexofytol), 46.67 mg turmeric rhizome extract per capsule with polysorbate 80 (E433) as emulsifier; low dose: 2脳2 capsules/day, high dose: 2脳3 capsules/day, duration 3 months Curcumin serum levels quantified (pharmacokinetics assessed); sColl2-1 biomarker of cartilage degradation measured (ELISA); no detailed quantification of curcuminoid composition reported Henrotin et al., 2019
Nigella sativa (Black Seed) USP Oil extracted from seeds Thymoquinone, linoleic acid, palmitic acid, oleic acid Huseini et al., 2022
Psidium guajava L. (Guava leaf) No pharmacopoeial monograph identified 1 g/day guava leaf extract capsule Ellagic acid identified; no total polyphenol content reported Kakuo et al., 2018
Perilla frutescens (L.) Britton var. frutescens JP (Perilla leaf), Chinese Pharmacopoeia Extract from leaves Isoegomaketone, perillaldehyde, anthocyanins, terpenoids, coumarins Kim et al., 2023
Derris scandens Benth. No pharmacopoeial monograph identified 800 mg/day of dried ethanolic extract (50% ethanol, reflux), standardized capsule (400 mg each), genistein-7-O-[rhamnopyranosyl-(1→6)-glucopyranoside] as major active. Genistein derivative quantified by UPLC; no total isoflavonoid content reported. Kuptniratsaikul et al., 2011
Curcuma domestica Valeton (Turmeric) Same as Curcuma longa (JP, USP, EP, BP) Curcuma domestica extract, 1500 mg/day Curcuminoids 75–85% (curcumin:demethoxycurcumin:bisdemethoxycurcumin = 1:0.59:0.23) Kuptniratsaikul et al., 2014
Curcuma longa L. (Turmeric) JP, USP, EP, BP 500 mg NR-INF-02 capsule twice daily (total 1,000 mg/day), polysaccharide-rich extract (12.6% w/w polysaccharides by HPLC) Polysaccharide content quantified; no curcuminoid analysis (curcuminoids explicitly removed) Madhu et al., 2013
Cucumis sativus L. (Cucumber) No pharmacopoeial monograph identified 10 mg twice daily Q-Actin™ aqueous extract, standardized to 1% IdoBR1 IdoBR1 iminosugar quantified Nash et al., 2018
Cucumis sativus (Cucumber) No pharmacopoeial monograph identified Standardized extract with iminosugar idoBR1 Iminosugar idoBR1 Nash et al., 2023
Curcuma longa L. (Turmeric) JP, USP, EP, BP Curcuminoids extract (C3 Complex®), 1500 mg/day in 3 divided doses Curcuminoids ≥95% (curcumin, demethoxycurcumin, bisdemethoxycurcumin); Bioperine® 5 mg/capsule Panahi et al., 2014
Elaeagnus angustifolia L. (Russian Olive) No pharmacopoeial monograph identified Aqueous extract syrup, 300 or 600 mg/day for 7 weeks Kaempferol 0.21% w/w (HPLC quantified); flavonoids and tannins (not fully quantified) Panahi et al., 2016
Curcuma longa L. JP, USP, EP, BP 500 mg/day Curene® capsule, Aquasome™ bioavailable curcuminoids Curcuminoids (no total content specified) Panda et al., 2018
Curcuma longa L. (Turmeric) JP, USP, EP, BP 1,000 mg/day curcuminoid capsules (2×250 mg bid), combined with diclofenac 75 mg/day Each capsule contained 250 mg turmeric extract equivalent to curcuminoids; no individual curcuminoid quantification Pinsornsak and Niempoog, 2012
Withania somnifera (Ashwagandha) USP Aqueous extract of root + leaf (Sensoril®), 125 or 250 mg twice daily Withanolide glycosides ≥10%, oligosaccharides ≥32%, Withaferin-A ≤0.5% (HPLC standardized) Ramakanth et al., 2016
Allium sativum L. (Garlic) BP, EP, USP 1000 mg/day odorless garlic tablet, 2.5 mg allicin Allicin quantified; no total sulfur compound content reported Salimzadeh et al., 2018
Prunus cerasus L. (Tart Cherry) No pharmacopoeial monograph identified Tart cherry juice blend (≥90% cherry juice), 8 oz twice daily for 6 weeks Phenolics ≥450 mg/bottle (as gallic acid equivalents); Anthocyanins ≥30 mg/bottle (as cyanidin-3-glucoside) Schumacher et al., 2013
Curcuma longa (Turmeric) JP, USP, EP, BP BCM-95 extract containing curcuminoids and essential oil of turmeric Curcumin, demethoxycurcumin, bisdemethoxycurcumin, ar-turmerone Singhal et al., 2021
Boswellia serrata Roxb. (Indian Frankincense) EP (resin) 333 mg Boswellia serrata extract capsule thrice daily (total 999 mg/day), standardized to ≥40% total boswellic acids Total boswellic acids quantified; individual acids reported (11-keto-β-BA: 6.44%, 3-O-acetyl-β-BA: 8.58%, etc.) Sontakke et al., 2007
Momordica charantia L. (Bitter melon) Chinese Pharmacopoeia; not in JP/USP/EP/BP 4500 mg/day whole fruit extract, 500 mg/capsule, 3 capsules TID No specific compound quantified; phytochemical screening mentioned May et al., 2018
Curcuma longa L. (Turmeric) JP, USP, EP, BP CL extract capsule (500 mg, 2× daily) for 4 months ≥95% curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin) Srivastava et al., 2016
Drimia maritima (Squill) EP, USP Oxymel syrup from squill vinegar extract and honey Bufadienolides (e.g., proscillaridin A) Taheri et al., 2023
Olea europaea L. (Olive leaf) EP, USP (leaf/oil); hydroxytyrosol not monographed 50.1 mg/day olive extract (HT-20), containing 10.04 mg hydroxytyrosol Hydroxytyrosol quantified by HPLC (22% of extract); no other phenolics quantified Takeda et al., 2013
Zingiber officinale (Ginger) JP, USP, EP, BP 250 mg Zintona EC capsule qid (total 1,000 mg/day), enteric-coated, supercritical CO₂ extract, 10 mg gingerol per capsule Gingerol content quantified by HPLC; dissolution tested (20% release in gastric fluid, remainder in intestinal fluid) Wigler et al., 2003
Zingiber officinale (Ginger) JP, USP, EP, BP 250 mg Zintoma capsule twice daily (total 500 mg/day), containing 250 mg powdered ginger per capsule No phytochemical quantification; only stated as “powdered ginger” Zakeri et al., 2011
3.4 Network meta-analysis

The complete NMA diagrams are presented in Figures 2A, 3A, 4A.

(A) NMA figure for Pain Score. (B) SUCRA plot for Pain Score.

Diagram A shows a network of connections between various extracts and treatments, highlighting relationships with placebos and usual treatments through varying line thicknesses. Diagram B displays cumulative probability graphs for each extract and treatment, with ranks ranging from 0 to 30 on the horizontal axis. Each graph illustrates how different treatments compare in terms of effectiveness.

(A) NMA figure for Stiffness Score. (B) SUCRA plot for Stiffness Score.

Diagram A shows a network of treatment comparisons involving placebo and various extracts, with line thickness indicating the number of studies. Larger nodes represent more comparisons. Diagram B presents multiple line graphs displaying cumulative probabilities for each treatment over a rank scale from zero to twenty-five. Each graph corresponds to a specific extract or treatment, showing how their probabilities increase with rank.

(A) NMA figure for Function Score. (B) SUCRA plot for Function Score.

A network diagram (Panel A) shows various extracts connected to placebo and usual treatment, with lines indicating relationships. Placebo has the most connections. Panel B contains multiple line graphs, each labeled with an extract or treatment, plotting cumulative probabilities against rank on a scale of zero to twenty-five. 3.4.1 Knee joint pain score

The p-values for all indirect and direct comparisons among the studies were tested for consistency and inconsistency, with all p-values exceeding 0.05, indicating that the influence of inconsistency among the studies was acceptable. We conducted global inconsistency test and found that the p value was 0.63. The DIC of consistency model was 201.4, while that of inconsistency model was 208.9. ΔDIC was all >5, indicating that the consistency model was supported. Detailed information is provided in Supplementary Table S2.

The results of the network meta-analysis showed that, compared to the control group using placebo, CS extract [SMD = 6.65, 95% CI = (3.83, 9.48)] and Ashwagandha extract [SMD = 3.78, 95% CI = (0.11, 7.45)] were more effective in reducing Pain scores. Compared to the control group receiving conventional treatment, CS extract [SMD = 6.44, 95% CI = (3.58, 9.31)] was also more effective in reducing Pain scores. In the probability ranking for reducing Pain scores among different botanical and medicinal plant extracts, CS extract ranked first in SUCRA (99.2%, see Figure 2B). The comparisons between the two different interventions are presented in Table 2.

 3.4.2 Knee joint stiffness score

The p-values for all indirect and direct comparisons across the studies were tested for consistency and inconsistency, with all p-values exceeding 0.05, indicating that the consistency among the studies was acceptable. We conducted global inconsistency test and found that the p value was 0.57. The DIC of consistency model was 176.8, while that of inconsistency model was 184.3. ΔDIC was all >5, indicating that the consistency model was supported. Detailed information is provided in Supplementary Table S3.

The results of the network meta-analysis showed that, compared to the placebo control group, Ashwagandha extract [SMD = 4.16, 95% CI = (2.43, 5.90)], CS extract [SMD = 3.74, 95% CI = (2.58, 4.90)], Jadwar extract [SMD = 1.74, 95% CI = (0.36, 3.11)], AP extract [SMD = 1.51, 95% CI = (0.10, 2.92)], and Curcuma extract [SMD = 0.79, 95% CI = (0.12, 1.47)] were more effective in reducing Stiff scores. Compared to the control group receiving conventional treatment, Ashwagandha extract [SMD = 3.90, 95% CI = (1.88, 5.91)] and CS extract [SMD = 3.48, 95% CI = (2.32, 4.64)] were more effective in reducing Stiff scores. In the probability ranking for reducing Stiff scores among different botanical and medicinal plant extracts, Ashwagandha extract ranked first in SUCRA (98.3%, see Figure 3B). Comparisons between the two different interventions are presented in Table 4.

League table on Stiffness Score.

Ashwagandha extract CS extract Jadwar extract AP extract NS extract Curcuma extract Curcuma extract NS extract GL extract EA extract Pomegranate extract GT extract
Ashwagandha extract 0.42 (−1.67,2.51) 2.42 (0.21,4.64) 2.65 (0.42,4.89) 3.04 (0.84,5.25) 3.37 (1.51,5.23) 3.54 (1.32,5.76) 3.68 (1.71,5.65) 3.69 (1.45,5.92) 3.72 (1.28,6.17) 3.74 (1.48,6.00) 3.77 (1.30,6.25)
−0.42 (−2.51,1.67) CS extract 2.00 (0.21,3.80) 2.23 (0.41,4.06) 2.62 (0.84,4.41) 2.95 (1.76,4.14) 3.12 (1.32,4.92) 3.26 (1.77,4.75) 3.27 (1.45,5.09) 3.31 (1.50,5.11) 3.32 (1.46,5.17) 3.36 (1.51,5.20)
−2.42 (−4.64,−0.21) −2.00 (−3.80,−0.21) Jadwar extract 0.23 (−1.74,2.20) 0.62 (−1.31,2.55) 0.94 (−0.59,2.48) 1.12 (−0.83,3.06) 1.25 (−0.41,2.92) 1.26 (−0.70,3.23) 1.30 (−0.91,3.51) 1.31 (−0.68,3.31) 1.35 (−0.89,3.59)
−2.65 (−4.89,−0.42) −2.23 (−4.06,−0.41) −0.23 (−2.20,1.74) AP extract 0.39 (−1.57,2.35) 0.72 (−0.84,2.28) 0.89 (−1.08,2.86) 1.03 (−0.66,2.72) 1.04 (−0.95,3.03) 1.07 (−1.15,3.30) 1.09 (−0.93,3.10) 1.12 (−1.14,3.38)
−3.04 (−5.25,−0.84) −2.62 (−4.41,−0.84) −0.62 (−2.55,1.31) −0.39 (−2.35,1.57) NS extract 0.32 (−1.20,1.84) 0.50 (−1.44,2.43) 0.63 (−1.02,2.29) 0.64 (−1.31,2.60) 0.68 (−1.52,2.88) 0.69 (−1.29,2.68) 0.73 (−1.50,2.96)
−3.37 (−5.23,−1.51) −2.95 (−4.14,−1.76) −0.94 (−2.48,0.59) −0.72 (−2.28,0.84) −0.32 (−1.84,1.20) Curcuma extract 0.17 (−1.36,1.71) 0.31 (−0.85,1.47) 0.32 (−1.24,1.88) 0.36 (−1.28,1.99) 0.37 (−1.23,1.97) 0.41 (−1.27,2.09)
−3.54 (−5.76,−1.32) −3.12 (−4.92,−1.32) −1.12 (−3.06,0.83) −0.89 (−2.86,1.08) −0.50 (−2.43,1.44) −0.17 (−1.71,1.36) Curcuma extract 0.14 (−1.53,1.80) 0.15 (−1.82,2.12) 0.18 (−2.02,2.39) 0.20 (−1.80,2.20) 0.23 (−2.01,2.47)
−3.68 (−5.65,−1.71) −3.26 (−4.75,−1.77) −1.25 (−2.92,0.41) −1.03 (−2.72,0.66) −0.63 (−2.29,1.02) −0.31 (−1.47,0.85) −0.14 (−1.80,1.53) NS extract 0.01 (−1.68,1.70) 0.05 (−1.92,2.01) 0.06 (−1.67,1.79) 0.10 (−1.90,2.10)
−3.69 (−5.92,−1.45) −3.27 (−5.09,−1.45) −1.26 (−3.23,0.70) −1.04 (−3.03,0.95) −0.64 (−2.60,1.31) −0.32 (−1.88,1.24) −0.15 (−2.12,1.82) −0.01 (−1.70,1.68) GL extract 0.04 (−2.19,2.26) 0.05 (−1.97,2.07) 0.09 (−2.17,2.35)
−3.72 (−6.17,−1.28) −3.31 (−5.11,−1.50) −1.30 (−3.51,0.91) −1.07 (−3.30,1.15) −0.68 (−2.88,1.52) −0.36 (−1.99,1.28) −0.18 (−2.39,2.02) −0.05 (−2.01,1.92) −0.04 (−2.26,2.19) EA extract 0.01 (−2.24,2.27) 0.05 (−1.95,2.05)
−3.74 (−6.00,−1.48) −3.32 (−5.17,−1.46) −1.31 (−3.31,0.68) −1.09 (−3.10,0.93) −0.69 (−2.68,1.29) −0.37 (−1.97,1.23) −0.20 (−2.20,1.80) −0.06 (−1.79,1.67) −0.05 (−2.07,1.97) −0.01 (−2.27,2.24) Pomegranate extract 0.04 (−2.25,2.32)
−3.77 (−6.25,−1.30) −3.36 (−5.20,−1.51) −1.35 (−3.59,0.89) −1.12 (−3.38,1.14) −0.73 (−2.96,1.50) −0.41 (−2.09,1.27) −0.23 (−2.47,2.01) −0.10 (−2.10,1.90) −0.09 (−2.35,2.17) −0.05 (−2.05,1.95) −0.04 (−2.32,2.25) GT extract
−3.88 (−6.31,−1.45) −3.46 (−5.24,−1.68) −1.46 (−3.64,0.73) −1.23 (−3.43,0.98) −0.84 (−3.01,1.34) −0.51 (−2.12,1.10) −0.34 (−2.53,1.85) −0.20 (−2.14,1.74) −0.19 (−2.40,2.01) −0.16 (−2.09,1.78) −0.14 (−2.37,2.09) −0.11 (−2.08,1.87)
−3.90 (−6.10,−1.69) −3.48 (−5.26,−1.69) −1.47 (−3.40,0.46) −1.24 (−3.20,0.71) −0.85 (−2.77,1.07) −0.53 (−2.04,0.99) −0.36 (−2.29,1.58) −0.22 (−1.87,1.43) −0.21 (−2.16,1.75) −0.17 (−2.37,2.02) −0.16 (−2.14,1.83) −0.12 (−2.35,2.11)
−3.91 (−6.18,−1.63) −3.49 (−5.36,−1.62) −1.48 (−3.49,0.53) −1.25 (−3.29,0.78) −0.86 (−2.87,1.14) −0.54 (−2.16,1.08) −0.37 (−2.38,1.65) −0.23 (−1.97,1.51) −0.22 (−2.25,1.82) −0.18 (−2.45,2.08) −0.17 (−2.23,1.89) −0.13 (−2.43,2.16)
−3.94 (−6.15,−1.72) −3.52 (−5.32,−1.72) −1.51 (−3.46,0.43) −1.28 (−3.25,0.68) −0.89 (−2.83,1.04) −0.57 (−2.10,0.97) −0.40 (−2.34,1.55) −0.26 (−1.92,1.41) −0.25 (−2.22,1.72) −0.21 (−2.42,2.00) −0.20 (−2.20,1.80) −0.16 (−2.40,2.08)
−3.90 (−5.91,−1.88) −3.48 (−4.64,−2.32) −1.47 (−3.19,0.24) −1.25 (−2.99,0.50) −0.85 (−2.56,0.85) −0.53 (−1.40,0.34) −0.36 (−2.08,1.36) −0.22 (−1.61,1.17) −0.21 (−1.95,1.53) −0.17 (−1.56,1.21) −0.16 (−1.94,1.61) −0.12 (−1.56,1.31)
−3.95 (−6.40,−1.51) −3.53 (−5.34,−1.73) −1.53 (−3.73,0.68) −1.30 (−3.53,0.92) −0.91 (−3.11,1.29) −0.58 (−2.22,1.05) −0.41 (−2.62,1.79) −0.27 (−2.24,1.69) −0.26 (−2.49,1.96) −0.23 (−2.19,1.73) −0.21 (−2.47,2.04) −0.18 (−2.18,1.82)
−3.96 (−6.24,−1.69) −3.55 (−5.42,−1.67) −1.54 (−3.56,0.47) −1.31 (−3.35,0.72) −0.92 (−2.93,1.08) −0.60 (−2.22,1.02) −0.43 (−2.44,1.59) −0.29 (−2.03,1.46) −0.28 (−2.31,1.76) −0.24 (−2.51,2.03) −0.23 (−2.29,1.84) −0.19 (−2.49,2.11)
−4.05 (−6.25,−1.85) −3.63 (−5.41,−1.85) −1.62 (−3.55,0.30) −1.40 (−3.35,0.55) −1.00 (−2.92,0.91) −0.68 (−2.19,0.83) −0.51 (−2.44,1.42) −0.37 (−2.01,1.27) −0.36 (−2.31,1.59) −0.32 (−2.51,1.87) −0.31 (−2.29,1.67) −0.27 (−2.50,1.95)
−4.06 (−6.30,−1.81) −3.64 (−5.48,−1.80) −1.64 (−3.62,0.34) −1.41 (−3.41,0.60) −1.02 (−2.99,0.95) −0.69 (−2.27,0.89) −0.52 (−2.50,1.46) −0.38 (−2.09,1.32) −0.37 (−2.37,1.63) −0.34 (−2.57,1.90) −0.32 (−2.35,1.71) −0.29 (−2.55,1.98)
−4.28 (−6.50,−2.06) −3.86 (−5.67,−2.05) −1.85 (−3.81,0.10) −1.63 (−3.60,0.35) −1.23 (−3.18,0.71) −0.91 (−2.45,0.63) −0.74 (−2.69,1.22) −0.60 (−2.27,1.07) −0.59 (−2.56,1.39) −0.55 (−2.77,1.66) −0.54 (−2.54,1.46) −0.50 (−2.75,1.74)
−4.16 (−5.90,−2.43) −3.74 (−4.90,−2.58) −1.74 (−3.11,−0.36) −1.51 (−2.92,−0.10) −1.12 (−2.48,0.24) −0.79 (−1.47,−0.12) −0.62 (−2.00,0.76) −0.48 (−1.42,0.45) −0.47 (−1.88,0.94) −0.44 (−2.16,1.29) −0.42 (−1.87,1.03) −0.39 (−2.15,1.38)
−4.30 (−6.50,−2.11) −3.89 (−5.66,−2.11) −1.88 (−3.80,0.04) −1.65 (−3.60,0.29) −1.26 (−3.17,0.65) −0.94 (−2.44,0.57) −0.76 (−2.69,1.16) −0.63 (−2.26,1.01) −0.62 (−2.56,1.33) −0.58 (−2.77,1.61) −0.57 (−2.54,1.41) −0.53 (−2.75,1.69)
DSB extract Argan extract PFP extract Zisu extract Usual treatment BS extract Pineapple extract CZ extract Cherry extract Fennel extract Placebo RIL extract
3.88 (1.45,6.31) 3.90 (1.69,6.10) 3.91 (1.63,6.18) 3.94 (1.72,6.15) 3.90 (1.88,5.91) 3.95 (1.51,6.40) 3.96 (1.69,6.24) 4.05 (1.85,6.25) 4.06 (1.81,6.30) 4.28 (2.06,6.50) 4.16 (2.43,5.90) 4.30 (2.11,6.50)
3.46 (1.68,5.24) 3.48 (1.69,5.26) 3.49 (1.62,5.36) 3.52 (1.72,5.32) 3.48 (2.32,4.64) 3.53 (1.73,5.34) 3.55 (1.67,5.42) 3.63 (1.85,5.41) 3.64 (1.80,5.48) 3.86 (2.05,5.67) 3.74 (2.58,4.90) 3.89 (2.11,5.66)
1.46 (−0.73,3.64) 1.47 (−0.46,3.40) 1.48 (−0.53,3.49) 1.51 (−0.43,3.46) 1.47 (−0.24,3.19) 1.53 (−0.68,3.73) 1.54 (−0.47,3.56) 1.62 (−0.30,3.55) 1.64 (−0.34,3.62) 1.85 (−0.10,3.81) 1.74 (0.36,3.11) 1.88 (−0.04,3.80)
1.23 (−0.98,3.43) 1.24 (−0.71,3.20) 1.25 (−0.78,3.29) 1.28 (−0.68,3.25) 1.25 (−0.50,2.99) 1.30 (−0.92,3.53) 1.31 (−0.72,3.35) 1.40 (−0.55,3.35) 1.41 (−0.60,3.41) 1.63 (−0.35,3.60) 1.51 (0.10,2.92) 1.65 (−0.29,3.60)
0.84 (−1.34,3.01) 0.85 (−1.07,2.77) 0.86 (−1.14,2.87) 0.89 (−1.04,2.83) 0.85 (−0.85,2.56) 0.91 (−1.29,3.11) 0.92 (−1.08,2.93) 1.00 (−0.91,2.92) 1.02 (−0.95,2.99) 1.23 (−0.71,3.18) 1.12 (−0.24,2.48) 1.26 (−0.65,3.17)
0.51 (−1.10,2.12) 0.53 (−0.99,2.04) 0.54 (−1.08,2.16) 0.57 (−0.97,2.10) 0.53 (−0.34,1.40) 0.58 (−1.05,2.22) 0.60 (−1.02,2.22) 0.68 (−0.83,2.19) 0.69 (−0.89,2.27) 0.91 (−0.63,2.45) 0.79 (0.12,1.47) 0.94 (−0.57,2.44)
0.34 (−1.85,2.53) 0.36 (−1.58,2.29) 0.37 (−1.65,2.38) 0.40 (−1.55,2.34) 0.36 (−1.36,2.08) 0.41 (−1.79,2.62) 0.43 (−1.59,2.44) 0.51 (−1.42,2.44) 0.52 (−1.46,2.50) 0.74 (−1.22,2.69) 0.62 (−0.76,2.00) 0.76 (−1.16,2.69)
0.20 (−1.74,2.14) 0.22 (−1.43,1.87) 0.23 (−1.51,1.97) 0.26 (−1.41,1.92) 0.22 (−1.17,1.61) 0.27 (−1.69,2.24) 0.29 (−1.46,2.03) 0.37 (−1.27,2.01) 0.38 (−1.32,2.09) 0.60 (−1.07,2.27) 0.48 (−0.45,1.42) 0.63 (−1.01,2.26)
0.19 (−2.01,2.40) 0.21 (−1.75,2.16) 0.22 (−1.82,2.25) 0.25 (−1.72,2.22) 0.21 (−1.53,1.95) 0.26 (−1.96,2.49) 0.28 (−1.76,2.31) 0.36 (−1.59,2.31) 0.37 (−1.63,2.37) 0.59 (−1.39,2.56) 0.47 (−0.94,1.88) 0.62 (−1.33,2.56)
0.16 (−1.78,2.09) 0.17 (−2.02,2.37) 0.18 (−2.08,2.45) 0.21 (−2.00,2.42) 0.17 (−1.21,1.56) 0.23 (−1.73,2.19) 0.24 (−2.03,2.51) 0.32 (−1.87,2.51) 0.34 (−1.90,2.57) 0.55 (−1.66,2.77) 0.44 (−1.29,2.16) 0.58 (−1.61,2.77)
0.14 (−2.09,2.37) 0.16 (−1.83,2.14) 0.17 (−1.89,2.23) 0.20 (−1.80,2.20) 0.16 (−1.61,1.94) 0.21 (−2.04,2.47) 0.23 (−1.84,2.29) 0.31 (−1.67,2.29) 0.32 (−1.71,2.35) 0.54 (−1.46,2.54) 0.42 (−1.03,1.87) 0.57 (−1.41,2.54)
0.11 (−1.87,2.08) 0.12 (−2.11,2.35) 0.13 (−2.16,2.43) 0.16 (−2.08,2.40) 0.12 (−1.31,1.56) 0.18 (−1.82,2.18) 0.19 (−2.11,2.49) 0.27 (−1.95,2.50) 0.29 (−1.98,2.55) 0.50 (−1.74,2.75) 0.39 (−1.38,2.15) 0.53 (−1.69,2.75)
DSB extract 0.02 (−2.16,2.19) 0.03 (−2.22,2.27) 0.06 (−2.13,2.24) 0.02 (−1.33,1.37) 0.07 (−1.86,2.01) 0.09 (−2.16,2.33) 0.17 (−2.00,2.34) 0.18 (−2.04,2.40) 0.40 (−1.79,2.59) 0.28 (−1.42,1.98) 0.42 (−1.74,2.59)
−0.02 (−2.19,2.16) Argan extract 0.01 (−1.99,2.01) 0.04 (−1.89,1.97) 0.00 (−1.70,1.70) 0.06 (−2.14,2.25) 0.07 (−1.93,2.07) 0.15 (−1.76,2.07) 0.16 (−1.80,2.13) 0.38 (−1.56,2.32) 0.27 (−1.09,1.62) 0.41 (−1.50,2.32)
−0.03 (−2.27,2.22) −0.01 (−2.01,1.99) PFP extract 0.03 (−1.98,2.04) −0.01 (−1.80,1.78) 0.05 (−2.22,2.31) 0.06 (−2.02,2.14) 0.14 (−1.85,2.14) 0.15 (−1.89,2.20) 0.37 (−1.65,2.39) 0.25 (−1.21,1.72) 0.40 (−1.59,2.39)
−0.06 (−2.24,2.13) −0.04 (−1.97,1.89) −0.03 (−2.04,1.98) Zisu extract −0.04 (−1.75,1.68) 0.02 (−2.19,2.22) 0.03 (−1.99,2.04) 0.11 (−1.82,2.04) 0.12 (−1.86,2.10) 0.34 (−1.61,2.29) 0.23 (−1.15,1.60) 0.37 (−1.55,2.29)
−0.02 (−1.37,1.33) −0.00 (−1.70,1.70) 0.01 (−1.78,1.80) 0.04 (−1.68,1.75) Usual treatment 0.05 (−1.33,1.44) 0.07 (−1.73,1.86) 0.15 (−1.55,1.85) 0.16 (−1.59,1.92) 0.38 (−1.34,2.10) 0.26 (−0.76,1.29) 0.41 (−1.28,2.09)
−0.07 (−2.01,1.86) −0.06 (−2.25,2.14) −0.05 (−2.31,2.22) −0.02 (−2.22,2.19) −0.05 (−1.44,1.33) BS extract 0.01 (−2.25,2.28) 0.09 (−2.10,2.28) 0.11 (−2.13,2.34) 0.33 (−1.89,2.54) 0.21 (−1.51,1.93) 0.35 (−1.83,2.54)
−0.09 (−2.33,2.16) −0.07 (−2.07,1.93) −0.06 (−2.14,2.02) −0.03 (−2.04,1.99) −0.07 (−1.86,1.73) −0.01 (−2.28,2.25) Pineapple extract 0.08 (−1.92,2.08) 0.09 (−1.96,2.14) 0.31 (−1.71,2.33) 0.20 (−1.28,1.67) 0.34 (−1.65,2.33)
−0.17 (−2.34,2.00) −0.15 (−2.07,1.76) −0.14 (−2.14,1.85) −0.11 (−2.04,1.82) −0.15 (−1.85,1.55) −0.09 (−2.28,2.10) −0.08 (−2.08,1.92) CZ extract 0.01 (−1.95,1.97) 0.23 (−1.70,2.17) 0.11 (−1.24,1.46) 0.26 (−1.65,2.16)
−0.18 (−2.40,2.04) −0.16 (−2.13,1.80) −0.15 (−2.20,1.89) −0.12 (−2.10,1.86) −0.16 (−1.92,1.59) −0.11 (−2.34,2.13) −0.09 (−2.14,1.96) −0.01 (−1.97,1.95) Cherry extract 0.22 (−1.77,2.21) 0.10 (−1.32,1.53) 0.25 (−1.71,2.20)
−0.40 (−2.59,1.79) −0.38 (−2.32,1.56) −0.37 (−2.39,1.65) −0.34 (−2.29,1.61) −0.38 (−2.10,1.34) −0.33 (−2.54,1.89) −0.31 (−2.33,1.71) −0.23 (−2.17,1.70) −0.22 (−2.21,1.77) Fennel extract −0.12 (−1.50,1.27) 0.03 (−1.90,1.95)
−0.28 (−1.98,1.42) −0.27 (−1.62,1.09) −0.25 (−1.72,1.21) −0.23 (−1.60,1.15) −0.26 (−1.29,0.76) −0.21 (−1.93,1.51) −0.20 (−1.67,1.28) −0.11 (−1.46,1.24) −0.10 (−1.53,1.32) 0.12 (−1.27,1.50) Placebo 0.14 (−1.20,1.48)
−0.42 (−2.59,1.74) −0.41 (−2.32,1.50) −0.40 (−2.39,1.59) −0.37 (−2.29,1.55) −0.41 (−2.09,1.28) −0.35 (−2.54,1.83) −0.34 (−2.33,1.65) −0.26 (−2.16,1.65) −0.25 (−2.20,1.71) −0.03 (−1.95,1.90) −0.14 (−1.48,1.20) RIL extract
3.4.3 Knee joint function score

The p-values for all indirect and direct comparisons across the studies were tested for consistency and inconsistency, with all p-values exceeding 0.05, indicating that the consistency among the studies was acceptable. We conducted global inconsistency test and found that the p value was 0.43. The DIC of consistency model was 223.7, while that of inconsistency model was 230.1. ΔDIC was all >5, indicating that the consistency model was supported. Detailed information is provided in Supplementary Table S4.

The results of the network meta-analysis showed that, compared to the placebo control group, CS extract [SMD = 4.28, 95% CI = (2.08, 6.49)], Ashwagandha extract [SMD = 4.32, 95% CI = (1.34, 7.31)], and Curcuma extract [SMD = 1.78, 95% CI = (0.44, 3.11)] were more effective in reducing Function scores. Compared to the control group receiving conventional treatment, CS extract [SMD = 2.94, 95% CI = (0.73, 5.15)] was more effective in reducing Function scores. In the probability ranking for reducing Function scores among different botanical and medicinal plant extracts, CS extract ranked first in SUCRA (94.6%, see Figure 4B). Comparisons between the two different interventions are presented in Table 5.

League table on Function Score.

CS extract Ashwagandha extract Jadwar extract Curcuma extract NS extract PFP extract GT extract Usual treatment NS extract DSB extracts EA extract AP extract
CS extract −0.04 (−3.75,3.67) 2.20 (−1.35,5.75) 2.51 (0.24,4.77) 2.67 (−0.27,5.62) 2.72 (−0.88,6.33) 2.81 (−0.76,6.38) 2.94 (0.73,5.15) 2.96 (−0.58,6.50) 2.95 (−0.59,6.48) 2.96 (−0.59,6.52) 3.16 (−0.39,6.71)
0.04 (−3.67,3.75) Ashwagandha extract 2.24 (−1.84,6.32) 2.55 (−0.72,5.82) 2.71 (−0.85,6.28) 2.76 (−1.36,6.89) 2.85 (−1.65,7.36) 2.98 (−0.54,6.51) 3.00 (−1.07,7.07) 2.99 (−1.49,7.47) 3.01 (−1.48,7.50) 3.20 (−0.88,7.28)
−2.20 (−5.75,1.35) −2.24 (−6.32,1.84) Jadwar extract 0.30 (−2.78,3.39) 0.47 (−2.93,3.87) 0.52 (−3.46,4.50) 0.61 (−3.76,4.99) 0.74 (−2.62,4.09) 0.76 (−3.17,4.68) 0.75 (−3.60,5.09) 0.76 (−3.59,5.12) 0.96 (−2.98,4.89)
−2.51 (−4.77,−0.24) −2.55 (−5.82,0.72) −0.30 (−3.39,2.78) Curcuma extract 0.17 (−2.20,2.53) 0.22 (−2.93,3.37) 0.31 (−2.87,3.49) 0.43 (−1.06,1.93) 0.45 (−2.62,3.53) 0.44 (−2.70,3.58) 0.46 (−2.70,3.62) 0.65 (−2.44,3.74)
−2.67 (−5.62,0.27) −2.71 (−6.28,0.85) −0.47 (−3.87,2.93) −0.17 (−2.53,2.20) NS extract 0.05 (−3.40,3.51) 0.14 (−3.76,4.04) 0.27 (−2.44,2.97) 0.29 (−3.10,3.68) 0.27 (−3.59,4.14) 0.29 (−3.59,4.17) 0.49 (−2.91,3.89)
−2.72 (−6.33,0.88) −2.76 (−6.89,1.36) −0.52 (−4.50,3.46) −0.22 (−3.37,2.93) −0.05 (−3.51,3.40) PFP extract 0.09 (−4.33,4.51) 0.22 (−3.20,3.63) 0.24 (−3.74,4.21) 0.22 (−4.17,4.62) 0.24 (−4.16,4.65) 0.44 (−3.55,4.42)
−2.81 (−6.38,0.76) −2.85 (−7.36,1.65) −0.61 (−4.99,3.76) −0.31 (−3.49,2.87) −0.14 (−4.04,3.76) −0.09 (−4.51,4.33) GT extract 0.13 (−2.68,2.93) 0.15 (−4.22,4.51) 0.13 (−3.81,4.07) 0.15 (−3.80,4.10) 0.35 (−4.03,4.72)
−2.94 (−5.15,−0.73) −2.98 (−6.51,0.54) −0.74 (−4.09,2.62) −0.43 (−1.93,1.06) −0.27 (−2.97,2.44) −0.22 (−3.63,3.20) −0.13 (−2.93,2.68) Usual treatment 0.02 (−3.33,3.37) 0.01 (−2.76,2.77) 0.03 (−2.76,2.81) 0.22 (−3.14,3.58)
−2.96 (−6.50,0.58) −3.00 (−7.07,1.07) −0.76 (−4.68,3.17) −0.45 (−3.53,2.62) −0.29 (−3.68,3.10) −0.24 (−4.21,3.74) −0.15 (−4.51,4.22) −0.02 (−3.37,3.33) NS extract −0.01 (−4.35,4.33) 0.01 (−4.35,4.36) 0.20 (−3.73,4.13)
−2.95 (−6.48,0.59) −2.99 (−7.47,1.49) −0.75 (−5.09,3.60) −0.44 (−3.58,2.70) −0.27 (−4.14,3.59) −0.22 (−4.62,4.17) −0.13 (−4.07,3.81) −0.01 (−2.77,2.76) 0.01 (−4.33,4.35) DSB extracts 0.02 (−3.90,3.94) 0.21 (−4.14,4.56)
−2.96 (−6.52,0.59) −3.01 (−7.50,1.48) −0.76 (−5.12,3.59) −0.46 (−3.62,2.70) −0.29 (−4.17,3.59) −0.24 (−4.65,4.16) −0.15 (−4.10,3.80) −0.03 (−2.81,2.76) −0.01 (−4.36,4.35) −0.02 (−3.94,3.90) EA extract 0.19 (−4.17,4.56)
−3.16 (−6.71,0.39) −3.20 (−7.28,0.88) −0.96 (−4.89,2.98) −0.65 (−3.74,2.44) −0.49 (−3.89,2.91) −0.44 (−4.42,3.55) −0.35 (−4.72,4.03) −0.22 (−3.58,3.14) −0.20 (−4.13,3.73) −0.21 (−4.56,4.14) −0.19 (−4.56,4.17) AP extract
−3.14 (−6.69,0.41) −3.18 (−7.67,1.31) −0.93 (−5.29,3.42) −0.63 (−3.79,2.53) −0.46 (−4.34,3.42) −0.41 (−4.82,3.99) −0.32 (−4.27,3.63) −0.20 (−2.98,2.58) −0.18 (−4.53,4.17) −0.19 (−4.11,3.73) −0.17 (−4.10,3.76) 0.02 (−4.34,4.38)
−3.57 (−7.11,−0.03) −3.61 (−7.68,0.46) −1.37 (−5.29,2.55) −1.07 (−4.14,2.01) −0.90 (−4.29,2.49) −0.85 (−4.82,3.13) −0.76 (−5.13,3.61) −0.63 (−3.98,2.71) −0.61 (−4.53,3.30) −0.62 (−4.96,3.71) −0.61 (−4.96,3.74) −0.41 (−4.34,3.51)
−3.59 (−7.14,−0.04) −3.63 (−7.71,0.45) −1.39 (−5.33,2.54) −1.09 (−4.17,2.00) −0.92 (−4.32,2.48) −0.87 (−4.85,3.11) −0.78 (−5.16,3.60) −0.65 (−4.01,2.70) −0.63 (−4.56,3.29) −0.65 (−4.99,3.70) −0.63 (−4.99,3.73) −0.43 (−4.37,3.50)
−3.71 (−7.26,−0.17) −3.76 (−7.83,0.32) −1.51 (−5.44,2.42) −1.21 (−4.29,1.87) −1.04 (−4.44,2.35) −0.99 (−4.97,2.99) −0.90 (−5.27,3.47) −0.78 (−4.13,2.58) −0.76 (−4.68,3.17) −0.77 (−5.11,3.58) −0.75 (−5.11,3.61) −0.56 (−4.49,3.38)
−3.97 (−7.54,−0.39) −4.01 (−8.11,0.09) −1.77 (−5.72,2.19) −1.46 (−4.57,1.65) −1.29 (−4.72,2.13) −1.24 (−5.25,2.76) −1.15 (−5.55,3.24) −1.03 (−4.41,2.35) −1.01 (−4.96,2.94) −1.02 (−5.39,3.35) −1.00 (−5.38,3.38) −0.81 (−4.77,3.15)
−4.08 (−7.64,−0.51) −4.12 (−8.21,−0.03) −1.87 (−5.82,2.07) −1.57 (−4.67,1.53) −1.40 (−4.82,2.01) −1.35 (−5.35,2.64) −1.26 (−5.65,3.12) −1.14 (−4.51,2.24) −1.12 (−5.06,2.82) −1.13 (−5.49,3.23) −1.11 (−5.48,3.26) −0.92 (−4.87,3.03)
−4.12 (−7.66,−0.57) −4.16 (−8.23,−0.08) −1.92 (−5.84,2.01) −1.61 (−4.69,1.47) −1.44 (−4.84,1.95) −1.39 (−5.37,2.58) −1.30 (−5.68,3.07) −1.18 (−4.53,2.17) −1.16 (−5.08,2.76) −1.17 (−5.51,3.17) −1.15 (−5.51,3.20) −0.96 (−4.89,2.97)
−4.21 (−7.77,−0.65) −4.25 (−8.34,−0.17) −2.01 (−5.95,1.93) −1.71 (−4.80,1.39) −1.54 (−4.94,1.87) −1.49 (−5.48,2.50) −1.40 (−5.78,2.98) −1.27 (−4.64,2.09) −1.25 (−5.18,2.68) −1.26 (−5.62,3.09) −1.25 (−5.61,3.12) −1.05 (−5.00,2.89)
−4.21 (−7.79,−0.62) −4.25 (−8.36,−0.14) −2.00 (−5.97,1.96) −1.70 (−4.82,1.43) −1.53 (−4.97,1.90) −1.48 (−5.50,2.53) −1.39 (−5.80,3.01) −1.27 (−4.66,2.13) −1.25 (−5.20,2.71) −1.26 (−5.63,3.12) −1.24 (−5.63,3.15) −1.05 (−5.01,2.92)
−4.22 (−7.75,−0.68) −4.26 (−8.32,−0.19) −2.01 (−5.93,1.90) −1.71 (−4.78,1.36) −1.54 (−4.92,1.84) −1.49 (−5.46,2.47) −1.40 (−5.76,2.96) −1.28 (−4.61,2.06) −1.26 (−5.17,2.65) −1.27 (−5.60,3.06) −1.25 (−5.60,3.09) −1.06 (−4.98,2.86)
−4.28 (−7.81,−0.74) −4.32 (−8.39,−0.25) −2.08 (−6.00,1.84) −1.77 (−4.84,1.30) −1.61 (−4.99,1.78) −1.55 (−5.53,2.42) −1.46 (−5.83,2.90) −1.34 (−4.68,2.00) −1.32 (−5.23,2.60) −1.33 (−5.67,3.01) −1.31 (−5.66,3.03) −1.12 (−5.04,2.81)
−4.28 (−6.49,−2.08) −4.32 (−7.31,−1.34) −2.08 (−4.86,0.70) −1.78 (−3.11,−0.44) −1.61 (−3.56,0.34) −1.56 (−4.41,1.29) −1.47 (−4.85,1.91) −1.34 (−3.22,0.53) −1.32 (−4.09,1.45) −1.34 (−4.68,2.01) −1.32 (−4.67,2.04) −1.12 (−3.91,1.66)
BS extract Argan extract Fennel extract Zisu extract Pomegranate extract Cherry extract Garlic extract GL extract Pineapple extract RIL extract CZ extract Placebo
3.14 (−0.41,6.69) 3.57 (0.03,7.11) 3.59 (0.04,7.14) 3.71 (0.17,7.26) 3.97 (0.39,7.54) 4.08 (0.51,7.64) 4.12 (0.57,7.66) 4.21 (0.65,7.77) 4.21 (0.62,7.79) 4.22 (0.68,7.75) 4.28 (0.74,7.81) 4.28 (2.08,6.49)
3.18 (−1.31,7.67) 3.61 (−0.46,7.68) 3.63 (−0.45,7.71) 3.76 (−0.32,7.83) 4.01 (−0.09,8.11) 4.12 (0.03,8.21) 4.16 (0.08,8.23) 4.25 (0.17,8.34) 4.25 (0.14,8.36) 4.26 (0.19,8.32) 4.32 (0.25,8.39) 4.32 (1.34,7.31)
0.93 (−3.42,5.29) 1.37 (−2.55,5.29) 1.39 (−2.54,5.33) 1.51 (−2.42,5.44) 1.77 (−2.19,5.72) 1.87 (−2.07,5.82) 1.92 (−2.01,5.84) 2.01 (−1.93,5.95) 2.00 (−1.96,5.97) 2.01 (−1.90,5.93) 2.08 (−1.84,6.00) 2.08 (−0.70,4.86)
0.63 (−2.53,3.79) 1.07 (−2.01,4.14) 1.09 (−2.00,4.17) 1.21 (−1.87,4.29) 1.46 (−1.65,4.57) 1.57 (−1.53,4.67) 1.61 (−1.47,4.69) 1.71 (−1.39,4.80) 1.70 (−1.43,4.82) 1.71 (−1.36,4.78) 1.77 (−1.30,4.84) 1.78 (0.44,3.11)
0.46 (−3.42,4.34) 0.90 (−2.49,4.29) 0.92 (−2.48,4.32) 1.04 (−2.35,4.44) 1.29 (−2.13,4.72) 1.40 (−2.01,4.82) 1.44 (−1.95,4.84) 1.54 (−1.87,4.94) 1.53 (−1.90,4.97) 1.54 (−1.84,4.92) 1.61 (−1.78,4.99) 1.61 (−0.34,3.56)
0.41 (−3.99,4.82) 0.85 (−3.13,4.82) 0.87 (−3.11,4.85) 0.99 (−2.99,4.97) 1.24 (−2.76,5.25) 1.35 (−2.64,5.35) 1.39 (−2.58,5.37) 1.49 (−2.50,5.48) 1.48 (−2.53,5.50) 1.49 (−2.47,5.46) 1.55 (−2.42,5.53) 1.56 (−1.29,4.41)
0.32 (−3.63,4.27) 0.76 (−3.61,5.13) 0.78 (−3.60,5.16) 0.90 (−3.47,5.27) 1.15 (−3.24,5.55) 1.26 (−3.12,5.65) 1.30 (−3.07,5.68) 1.40 (−2.98,5.78) 1.39 (−3.01,5.80) 1.40 (−2.96,5.76) 1.46 (−2.90,5.83) 1.47 (−1.91,4.85)
0.20 (−2.58,2.98) 0.63 (−2.71,3.98) 0.65 (−2.70,4.01) 0.78 (−2.58,4.13) 1.03 (−2.35,4.41) 1.14 (−2.24,4.51) 1.18 (−2.17,4.53) 1.27 (−2.09,4.64) 1.27 (−2.13,4.66) 1.28 (−2.06,4.61) 1.34 (−2.00,4.68) 1.34 (−0.53,3.22)
0.18 (−4.17,4.53) 0.61 (−3.30,4.53) 0.63 (−3.29,4.56) 0.76 (−3.17,4.68) 1.01 (−2.94,4.96) 1.12 (−2.82,5.06) 1.16 (−2.76,5.08) 1.25 (−2.68,5.18) 1.25 (−2.71,5.20) 1.26 (−2.65,5.17) 1.32 (−2.60,5.23) 1.32 (−1.45,4.09)
0.19 (−3.73,4.11) 0.62 (−3.71,4.96) 0.65 (−3.70,4.99) 0.77 (−3.58,5.11) 1.02 (−3.35,5.39) 1.13 (−3.23,5.49) 1.17 (−3.17,5.51) 1.26 (−3.09,5.62) 1.26 (−3.12,5.63) 1.27 (−3.06,5.60) 1.33 (−3.01,5.67) 1.34 (−2.01,4.68)
0.17 (−3.76,4.10) 0.61 (−3.74,4.96) 0.63 (−3.73,4.99) 0.75 (−3.61,5.11) 1.00 (−3.38,5.38) 1.11 (−3.26,5.48) 1.15 (−3.20,5.51) 1.25 (−3.12,5.61) 1.24 (−3.15,5.63) 1.25 (−3.09,5.60) 1.31 (−3.03,5.66) 1.32 (−2.04,4.67)
−0.02 (−4.38,4.34) 0.41 (−3.51,4.34) 0.43 (−3.50,4.37) 0.56 (−3.38,4.49) 0.81 (−3.15,4.77) 0.92 (−3.03,4.87) 0.96 (−2.97,4.89) 1.05 (−2.89,5.00) 1.05 (−2.92,5.01) 1.06 (−2.86,4.98) 1.12 (−2.81,5.04) 1.12 (−1.66,3.91)
BS extract 0.44 (−3.91,4.79) 0.46 (−3.90,4.82) 0.58 (−3.78,4.93) 0.83 (−3.55,5.21) 0.94 (−3.43,5.31) 0.98 (−3.37,5.34) 1.08 (−3.29,5.44) 1.07 (−3.32,5.46) 1.08 (−3.26,5.42) 1.14 (−3.20,5.49) 1.15 (−2.21,4.50)
−0.44 (−4.79,3.91) Argan extract 0.02 (−3.90,3.95) 0.14 (−3.78,4.06) 0.40 (−3.55,4.34) 0.50 (−3.43,4.44) 0.55 (−3.37,4.47) 0.64 (−3.29,4.57) 0.63 (−3.32,4.59) 0.64 (−3.26,4.55) 0.71 (−3.21,4.62) 0.71 (−2.06,3.48)
−0.46 (−4.82,3.90) −0.02 (−3.95,3.90) Fennel extract 0.12 (−3.81,4.05) 0.37 (−3.58,4.33) 0.48 (−3.46,4.43) 0.52 (−3.41,4.46) 0.62 (−3.32,4.56) 0.61 (−3.35,4.58) 0.62 (−3.30,4.54) 0.68 (−3.24,4.61) 0.69 (−2.09,3.47)
−0.58 (−4.93,3.78) −0.14 (−4.06,3.78) −0.12 (−4.05,3.81) Zisu extract 0.25 (−3.70,4.20) 0.36 (−3.58,4.31) 0.40 (−3.52,4.33) 0.50 (−3.44,4.43) 0.49 (−3.47,4.45) 0.50 (−3.41,4.42) 0.56 (−3.36,4.48) 0.57 (−2.21,3.35)
−0.83 (−5.21,3.55) −0.40 (−4.34,3.55) −0.37 (−4.33,3.58) −0.25 (−4.20,3.70) Pomegranate extract 0.11 (−3.86,4.08) 0.15 (−3.80,4.10) 0.24 (−3.72,4.21) 0.24 (−3.75,4.22) 0.25 (−3.69,4.19) 0.31 (−3.63,4.25) 0.32 (−2.50,3.13)
−0.94 (−5.31,3.43) −0.50 (−4.44,3.43) −0.48 (−4.43,3.46) −0.36 (−4.31,3.58) −0.11 (−4.08,3.86) Cherry extract 0.04 (−3.90,3.98) 0.14 (−3.82,4.09) 0.13 (−3.85,4.11) 0.14 (−3.79,4.07) 0.20 (−3.73,4.14) 0.21 (−2.59,3.01)
−0.98 (−5.34,3.37) −0.55 (−4.47,3.37) −0.52 (−4.46,3.41) −0.40 (−4.33,3.52) −0.15 (−4.10,3.80) −0.04 (−3.98,3.90) Garlic extract 0.09 (−3.84,4.03) 0.09 (−3.87,4.05) 0.10 (−3.81,4.01) 0.16 (−3.76,4.08) 0.17 (−2.61,2.94)
−1.08 (−5.44,3.29) −0.64 (−4.57,3.29) −0.62 (−4.56,3.32) −0.50 (−4.43,3.44) −0.24 (−4.21,3.72) −0.14 (−4.09,3.82) −0.09 (−4.03,3.84) GL extract −0.01 (−3.98,3.97) 0.00 (−3.92,3.93) 0.07 (−3.86,3.99) 0.07 (−2.72,2.86)
−1.07 (−5.46,3.32) −0.63 (−4.59,3.32) −0.61 (−4.58,3.35) −0.49 (−4.45,3.47) −0.24 (−4.22,3.75) −0.13 (−4.11,3.85) −0.09 (−4.05,3.87) 0.01 (−3.97,3.98) Pineapple extract 0.01 (−3.94,3.96) 0.07 (−3.88,4.02) 0.08 (−2.75,2.90)
−1.08 (−5.42,3.26) −0.64 (−4.55,3.26) −0.62 (−4.54,3.30) −0.50 (−4.42,3.41) −0.25 (−4.19,3.69) −0.14 (−4.07,3.79) −0.10 (−4.01,3.81) −0.00 (−3.93,3.92) −0.01 (−3.96,3.94) RIL extract 0.06 (−3.84,3.97) 0.07 (−2.69,2.83)
−1.14 (−5.49,3.20) −0.71 (−4.62,3.21) −0.68 (−4.61,3.24) −0.56 (−4.48,3.36) −0.31 (−4.25,3.63) −0.20 (−4.14,3.73) −0.16 (−4.08,3.76) −0.07 (−3.99,3.86) −0.07 (−4.02,3.88) −0.06 (−3.97,3.84) CZ extract 0.00 (−2.76,2.77)
−1.15 (−4.50,2.21) −0.71 (−3.48,2.06) −0.69 (−3.47,2.09) −0.57 (−3.35,2.21) −0.32 (−3.13,2.50) −0.21 (−3.01,2.59) −0.17 (−2.94,2.61) −0.07 (−2.86,2.72) −0.08 (−2.90,2.75) −0.07 (−2.83,2.69) −0.00 (−2.77,2.76) Placebo
3.5 Adverse events and safety outcomes

In terms of safety, the included botanical and plant-based preparations were generally well tolerated. Across trials, most adverse events were mild and gastrointestinal in nature. For example, ginger extract was associated with dyspepsia or heartburn in a small number of participants but without any treatment-related serious adverse events (Altman and Marcussen, 2001; Wigler et al., 2003). Bromelain mainly caused transient gastrointestinal upset without severe consequences (Brien et al., 2006). In a trial of curcumin co-administered with diclofenac, adverse events such as renal impairment and allergic swelling occurred only in the diclofenac group, whereas the combination group reported only a single case of hair loss (Pinsornsak and Niempoog, 2012). More recently, perilla extract was associated with only mild and unlikely drug-related adverse events and no laboratory abnormalities (Kim et al., 2023). Overall, no trial reported life-threatening or irreversible harms, and in several studies the safety profile compared favorably with conventional pharmacological comparators.

 3.6 Publication bias test

We constructed independent funnel plots for all outcome measures to assess potential publication bias. Visual inspection of the funnel plots revealed no significant evidence of publication bias. Detailed information is presented in Figure 5.

Funnel plot on publication bias. (a) Pain Score; (b) Stiffness Score; (c) Function score.

Three funnel plots labeled a, b, and c show the standard error of effect size versus the effect size centered at comparison-specific pooled effect. Each plot features points in various colors representing different comparisons, with a table below each identifying these comparisons. Dashed lines indicate the expected funnel shape in each plot. 4 Discussion

This study compared the efficacy of various botanical and medicinal plant extract interventions in treating patients with KOA. A total of 36 studies, comprising 26 different botanical and medicinal plant extracts and 3,285 patients diagnosed with KOA, were included. Our analysis indicated that CS extract was the most effective botanical and medicinal plant extract for reducing knee pain scores and functional impairment scores, while Ashwagandha extract demonstrated better efficacy in reducing knee stiffness scores. Overall, we consider CS extract to be the most suitable intervention for improving KOA symptoms. Given that there are only two studies with high homogeneity but small sample size for Cucumis sativus, the first result should be regarded as an exploratory signal and needs to be verified by a large sample multi-center RCT with independent teams.

From the results, it is evident that CS extract demonstrated the most significant therapeutic effect in alleviating pain scores among patients. Pain is the predominant symptom of KOA, typically characterized by mild to severe aching discomfort within the joint. In more severe instances, patients may experience tearing or pinprick sensations that persist even during rest and are often influenced by changes in weather conditions. The pathophysiology of KOA pain primarily arises from degenerative wear of joint cartilage, leading to an uneven articular surface that causes friction and impact during movement (Gelber, 2024). Furthermore, synovial inflammation due to cartilage damage releases inflammatory mediators that stimulate nerve endings, further contributing to joint pain (Tudorachi et al., 2021). CS extract contains a rare imino sugar amino acid, idoBR1 (Olajide et al., 2022), which has emerged as a novel anti-inflammatory molecule with excellent oral bioavailability and in vivo stability. Imino sugar amino acids are extremely rare in nature and exhibit no significant functional or structural similarity to current drugs for the treatment of osteoarthritis. Studies have shown that idoBR1 can effectively inhibit lipopolysaccharide (LPS)-induced production of the pro-inflammatory cytokine TNF-α in human serum and THP-1 cells, where elevated TNF-α levels are a key factor in degenerative changes (Nash et al., 2023). Additionally, idoBR1 was found to dose-dependently reduce LPS-induced TNF-α levels and significantly suppress multiple inflammatory markers, including interleukin-6 (IL-6), nitric oxide (NO), and transcription factor NF-κB, demonstrating its comprehensive anti-inflammatory potential(Nash et al., 2020; Olajide et al., 2022). The meta-analysis included two RCTs on CS extract, which showed that it exhibited the best therapeutic effects in improving pain. Additionally, its SUCRA ranking was second for alleviating knee stiffness. While Curcuma extract and BS extract have been promising in recent studies for KOA treatment (Liu et al., 2018; Yu et al., 2020), our study found CS extract to be more effective than both. In addition, other extracts are also considered to have certain clinical value, Ashwagandha extract can significantly reduce the release of pro-inflammatory cytokines such as IL-1β and TNF-α in synovial fluid monocytes by inhibiting the activation of the NF-κB signaling pathway, thereby alleviating the inflammatory response of knee joint synovium. It can also cooperate with chondroitin sulfate to upregulate the synthesis of glycosaminoglycans (GAGs) in articular cartilage and reduce the excessive production of nitric oxide (NO), thereby maintaining the homeostasis of cartilage matrix. The main active metabolite of Curcuma, curcumin, can block the NF-κB and MAPK cascades, inhibit the expression of cartilage-degrading enzymes such as MMP-3 and MMP-13, and thereby delay the destruction of articular cartilage. At the same time, curcumin can reduce oxidative stress damage in the joint cavity by enhancing the activity of superoxide dismutase (SOD) and reducing lipid peroxidation products, further improving the microenvironment of knee osteoarthritis.

Patients with KOA often experience joint stiffness, reduced fluidity of movement, and even locking sensations during activity, with stiffness being particularly prominent in the morning. These symptoms are often accompanied by joint swelling, pain, and restricted range of motion. The pathophysiology is complex, involving inflammation-induced synovial hyperplasia, congestion, and edema, along with structural changes such as capsular thickening and contracture, which significantly impair normal joint movement (Gelber, 2024). Inflammation may also lead to the accumulation of synovial fluid in the joint cavity, further exacerbating restrictions in joint mobility (Tudorachi et al., 2021). Prolonged inflammation can result in tension, spasms, and even atrophy of the surrounding muscles, further worsening joint stiffness and creating a vicious cycle. Ashwagandha (Indian ginseng) is a traditional Ayurvedic botanical drug. A previous study reported that Ashwagandha extract significantly reduced NO release in cartilage samples from osteoarthritis patients, demonstrating its anti-inflammatory effects (Sumantran et al., 2008). Clinically, it has been shown that after 4 and 8 weeks of Ashwagandha extract administration in KOA patients, patients showed statistically significant reductions in all efficacy variables in a dose-dependent manner (Ramakanth et al., 2016). However, studies on this botanical medicine remain limited, and its mechanisms and potential benefits in alleviating joint stiffness require further investigation.

Similarly, CS extract demonstrated the most effective treatment in reducing knee functional limitation scores. The degenerative wear and destruction of articular cartilage, reactive proliferation of subchondral bone forming osteophytes, and inflammatory reactions in the joint synovium result in abnormal joint structure, thereby affecting normal joint function (Gelber, 2024). The superior anti-inflammatory properties of CS extract exhibit better therapeutic outcomes in clinical practice compared to both placebo and chondroitin sulfate.

In conclusion, this study has a certain clinical significance. CS extract has a significant effect on relieving pain, stiffness and functional improvement of knee osteoarthritis, and it is a good natural extract for the treatment of KOA.

 5 Strengths and limitations

Our study included 36 studies and 3,285 patients, representing a relatively large sample size. We summarized the efficacy of various botanical and medicinal plant extracts for treating KOA patients from databases, with each study comparing botanical and medicinal plant extracts to placebo or conventional treatment interventions, providing updated and more comprehensive evidence-based recommendations.

However, our study shares some common limitations with the studies on which it is based. Although we made every effort to control for heterogeneity when including the original studies, heterogeneity between studies was inevitable (e.g., differences in the proportion of studies conducted in various regions and gender disparities among participants). Although 36 studies were included in our analysis, the number of studies for each type of botanical and medicinal plant extract was relatively small, with most botanical and medicinal plant extracts supported by only 1–2 RCTs. In addition, certain studies had limited evaluation criteria, and their results should be interpreted with caution. This highlights the need for further research to expand the evidence base. Most of the clinical trials included in this systematic review were conducted by Asian research teams, and the subjects were mainly from Asian populations. Due to differences in genetic background, lifestyle, dietary habits, and physical constitution, the efficacy and safety of botanical interventions observed in Asian populations may not be directly extrapolated to other racial or regional populations. Therefore, the applicability of the existing evidence to non-Asian populations remains uncertain. Currently, nearly all plant extracts/formulations in the field are only compared with placebos or conventional treatments, resulting in a severe lack of head-to-head randomized controlled trials (RCTs). To reduce uncertainties from indirect comparisons, future studies should prioritize multi-arm designs or platform trials that directly compare 2-3 of the most promising botanical extracts. Standardizing dosage regimens, treatment durations, and outcome measures will enhance the robustness of network meta-analysis results.

 6 Conclusion

Based on our findings, we recommend CS extract for patients seeking to alleviate knee pain and improve joint function, and Ashwagandha extract for those aiming to reduce knee stiffness. Overall, CS extract is the most recommended botanical and medicinal plant extract for osteoarthritis patients aiming to improve overall knee joint symptoms.

This study has been registered with PROSPERO, registration number: CRD42024617459.

 Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.

 Author contributions

CY: Data curation, Project administration, Writing – original draft. XD: Formal Analysis, Supervision, Writing – original draft. YL: Writing – original draft, Visualization, Validation. FX: Resources, Software, Writing – original draft. HY: Writing – original draft, Methodology, Investigation. YZ: Funding acquisition, Writing – review and editing, Resources. TB: Conceptualization, Writing – review and editing, Funding acquisition.

 Funding

The author(s) declare that financial support was received for the research and/or publication of this article. Project supported by Nanjing medical science and technology development fund (Grant Nos. YKK24214).

 Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

 Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

 Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

 Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2025.1619589/full#supplementary-material

References Alazadeh M. Azadbakht M. Niksolat F. Asgarirad H. Moosazadeh M. Ahmadi A. (2020). Effect of sweet fennel seed extract capsule on knee pain in women with knee osteoarthritis. Complement. Ther. Clin. Pract. 40, 101219. 10.1016/j.ctcp.2020.101219 32835919 Altman R. D. Marcussen K. C. (2001). Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum. 44 (11), 2531–2538. 10.1002/1529-0131(200111)44:11<2531::aid-art433>3.0.co;2-j 11710709 Bedenbaugh A. V. Bonafede M. Marchlewicz E. H. Lee V. Tambiah J. (2021). Real-world health care resource utilization and costs among US patients with knee osteoarthritis compared with controls. Clin. Outcomes Res. 13, 421–435. 10.2147/CEOR.S302289 34054301 Brien S. Lewith G. Walker A. F. Middleton R. Prescott P. Bundy R. (2006). Bromelain as an adjunctive treatment for moderate-to-severe osteoarthritis of the knee: a randomized placebo-controlled pilot study. Qjm-an Int. J. Med. 99 (12), 841–850. 10.1093/qjmed/hcl118 17121765 Chaimani A. Higgins J. P. Mavridis D. Spyridonos P. Salanti G. (2013). Graphical tools for network meta-analysis in STATA. PLoS One 8 (10), e76654. 10.1371/journal.pone.0076654 24098547 Charlesworth J. Fitzpatrick J. Perera N. K. P. Orchard J. (2019). Osteoarthritis-a systematic review of long-term safety implications for osteoarthritis of the knee. BMC Musculoskelet. Disord. 20 (1), 151. 10.1186/s12891-019-2525-0 30961569 Chen N. Fong D. Y. T. Wong J. Y. H. (2022). Secular trends in musculoskeletal rehabilitation needs in 191 countries and territories from 1990 to 2019. JAMA Netw. Open 5 (1), e2144198. 10.1001/jamanetworkopen.2021.44198 35044468 da Costa B. R. Reichenbach S. Keller N. Nartey L. Wandel S. Juni P. (2017). Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet 390 (10090), e21–e33. 10.1016/S0140-6736(17)31744-0 28699595 Eftekhar Sadat B. Khadem Haghighian M. Alipoor B. Malek Mahdavi A. Asghari Jafarabadi M. Moghaddam A. (2013). Effects of sesame seed supplementation on clinical signs and symptoms in patients with knee osteoarthritis. Int. J. Rheum. Dis. 16 (5), 578–582. 10.1111/1756-185x.12133 24164846 Essouiri J. Harzy T. Benaicha N. Errasfa M. Abourazzak F. E. (2017). Effectiveness of argan oil consumption on knee osteoarthritis symptoms: a randomized controlled clinical trial. Curr. Rheumatol. Rev. 13 (3), 231–235. 10.2174/1573397113666170710123031 28699499 Farid R. Rezaieyazdi Z. Mirfeizi Z. Hatef M. R. Mirheidari M. Mansouri H. (2010). Oral intake of purple passion fruit peel extract reduces pain and stiffness and improves physical function in adult patients with knee osteoarthritis. Nutr. Res. (New York, N.Y.) 30 (9), 601–606. 10.1016/j.nutres.2010.08.010 20934601 Gelber A. C. (2024). Knee osteoarthritis. Ann. Intern Med. 177 (9), ITC129–ITC144. 10.7326/ANNALS-24-01249 39250809 Ghoochani N. Karandish M. Mowla K. Haghighizadeh M. H. Jalalid M. T. (2016). The effect of pomegranate juice on clinical signs, matrix metalloproteinases and antioxidant status in patients with knee osteoarthritis. J. Sci. Food Agric. 96 (13), 4377–4381. 10.1002/jsfa.7647 26804926 Giordano R. Petersen K. K. Andersen H. H. Simonsen O. Arendt-Nielsen L. (2020). Serum inflammatory markers in patients with knee osteoarthritis: a proteomic approach. Clin. J. Pain 36 (4), 229–237. 10.1097/AJP.0000000000000804 31977377 Ha J. K. Kim J. S. Kim J. Y. Yun J. B. Kim Y. Y. Chung K. S. (2021). Efficacy of GCWB106 (Chrysanthemum zawadskii var. latilobum extract) in osteoarthritis of the knee: a 12-week randomized, double-blind, placebo-controlled study. Med. Baltim. 100 (26), e26542. 10.1097/md.0000000000026542 34190191 Hancke J. L. Srivastav S. Cáceres D. D. Burgos R. A. (2019). A double-blind, randomized, placebo-controlled study to assess the efficacy of Andrographis paniculata standardized extract (ParActin®) on pain reduction in subjects with knee osteoarthritis. Phytother. Res. 33 (5), 1469–1479. 10.1002/ptr.6339 30968986 Hannon C. P. Goodman S. M. Austin M. S. Yates A. Jr. Guyatt G. Aggarwal V. K. (2023). 2023 American college of rheumatology and American association of hip and knee surgeons clinical practice guideline for the optimal timing of elective hip or knee arthroplasty for patients with symptomatic moderate-to-severe osteoarthritis or Advanced symptomatic Osteonecrosis with secondary Arthritis for whom Nonoperative therapy is ineffective. Arthritis Rheumatol. 75 (11), 1877–1888. 10.1002/art.42630 37746897 Hashempur M. H. Sadrneshin S. Mosavat S. H. Ashraf A. (2018). Green tea (Camellia sinensis) for patients with knee osteoarthritis: a randomized open-label active-controlled clinical trial. Clin. Nutr. 37 (1), 85–90. 10.1016/j.clnu.2016.12.004 28038881 Henrotin Y. Malaise M. Wittoek R. de Vlam K. Brasseur J. P. Luyten F. P. (2019). Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study. Arthritis Res. Ther. 21 (1), 179. 10.1186/s13075-019-1960-5 31351488 Henrotin Y. Cozannet R. L. Fança-Berthon P. Truillet R. Cohen-Solhal M. DunnGalvin G. (2022). Rubus idaeus extract improves symptoms in knee osteoarthritis patients: results from a phase II double-blind randomized controlled trial. BMC Musculoskelet. Disord. 23 (1), 650. 10.1186/s12891-022-05612-2 35799169 Higgins J. P. Altman D. G. Gotzsche P. C. Juni P. Moher D. Oxman A. D. (2011). The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343, d5928. 10.1136/bmj.d5928 22008217 Huseini H. F. Mohtashami R. Sadeghzadeh E. Shadmanfar S. Hashem-Dabaghian F. Kianbakht S. (2022). Efficacy and safety of oral Nigella sativa oil for symptomatic treatment of knee osteoarthritis: a double-blind, randomized, placebo-controlled clinical trial. Complement. Ther. Clin. Pract. 49, 101666. 10.1016/j.ctcp.2022.101666 36150238 Jackson D. Riley R. White I. R. (2011). Multivariate meta-analysis: potential and promise. Stat. Med. 30 (20), 2481–2498. 10.1002/sim.4172 21268052 Jin X. Liang W. Zhang L. Cao S. Yang L. Xie F. (2023). Economic and humanistic burden of osteoarthritis: an updated systematic review of large sample studies. Pharmacoeconomics 41 (11), 1453–1467. 10.1007/s40273-023-01296-1 37462839 Kakuo S. Fushimi T. Kawasaki K. Nakamura J. Ota N. (2018). Effects of Psidium guajava Linn. leaf extract in Japanese subjects with knee pain: a randomized, double-blind, placebo-controlled, parallel pilot study. Aging Clin. Exp. Res. 30 (11), 1391–1398. 10.1007/s40520-018-0953-6 29687303 Khera R. Murad M. H. Chandar A. K. Dulai P. S. Wang Z. Prokop L. J. (2016). Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA 315 (22), 2424–2434. 10.1001/jama.2016.7602 27299618 Kim N. Kim S.-Y. Kim S.-W. Lee J. M. Kim S.-K. Park M.-H. (2023). Efficacy of Perilla frutescens (L.) Britton var. frutescens extract on mild knee joint pain: a randomized controlled trial. Front. Pharmacol. 14, 1114410. 10.3389/fphar.2023.1114410 36998613 Kolasinski S. L. Neogi T. Hochberg M. C. Oatis C. Guyatt G. Block J. (2020). 2019 American college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res. Hob. 72 (2), 149–162. 10.1002/acr.24131 31908149 Kuptniratsaikul V. Pinthong T. Bunjob M. Thanakhumtorn S. Chinswangwatanakul P. Thamlikitkul V. (2011). Efficacy and safety of Derris scandens Benth extracts in patients with knee osteoarthritis. J. Altern. Complement. Med. 17 (2), 147–153. 10.1089/acm.2010.0213 21309709 Kuptniratsaikul V. Dajpratham P. Taechaarpornkul W. Buntragulpoontawee M. Lukkanapichonchut P. Chootip C. (2014). Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin. Interv. Aging 9, 451–458. 10.2147/cia.S58535 24672232 Li D. Chen P. (2021). Effects of aquatic exercise and land-based exercise on cardiorespiratory fitness, motor function, balance, and functional independence in stroke patients-A meta-analysis of randomized controlled trials. Brain Sci. 11 (8), 1097. 10.3390/brainsci11081097 34439716 Liang Y. Xu Y. Zhu Y. Ye H. Wang Q. Xu G. (2022). Efficacy and safety of Chinese herbal medicine for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Phytomedicine 100, 154029. 10.1016/j.phymed.2022.154029 35316726 Lin Z. Zheng J. Chen M. Chen J. Lin J. (2022). The efficacy and safety of Chinese herbal medicine in the treatment of knee osteoarthritis: an updated systematic review and meta-analysis of 56 randomized controlled trials. Oxid. Med. Cell Longev. 2022, 6887988. 10.1155/2022/6887988 35035664 Liu X. Machado G. C. Eyles J. P. Ravi V. Hunter D. J. (2018). Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br. J. Sports Med. 52 (3), 167–175. 10.1136/bjsports-2016-097333 29018060 Long H. Liu Q. Yin H. Wang K. Diao N. Zhang Y. (2022). Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019. Arthritis Rheumatol. 74 (7), 1172–1183. 10.1002/art.42089 35233975 Madhu K. Chanda K. Saji M. J. (2013). Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial. Inflammopharmacology 21 (2), 129–136. 10.1007/s10787-012-0163-3 23242572 May L. S. Sanip Z. Shokri A. A. Kadir A. A. Lazin M. R. M. (2018). The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: a single-blinded, randomized controlled trial. Complementary Ther. Clin. Pract. 32, 181–186. 10.1016/j.ctcp.2018.06.012 Menon J. Mishra P. (2018). Health care resource use, health care expenditures and absenteeism costs associated with osteoarthritis in US healthcare system. Osteoarthr. Cartil. 26 (4), 480–484. 10.1016/j.joca.2017.12.007 29269328 Moher D. Shamseer L. Clarke M. Ghersi D. Liberati A. Petticrew M. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 4 (1), 1. 10.1186/2046-4053-4-1 25554246 Nash R. J. Azantsa B. K. Sharp H. Shanmugham V. (2018). Effectiveness of Cucumis sativus extract versus glucosamine-chondroitin in the management of moderate osteoarthritis: a randomized controlled trial. Clin. Interv. Aging 13, 2119–2126. 10.2147/cia.S173227 30498336 Nash R. J. Bartholomew B. Penkova Y. B. Rotondo D. Yamasaka F. Stafford G. P. (2020). Iminosugar idoBR1 isolated from cucumber Cucumis sativus reduces inflammatory activity. ACS Omega 5 (26), 16263–16271. 10.1021/acsomega.0c02092 32656449 Nash R. J. Mafongang A. Singh H. Singwe-Ngandeu M. Penkova Y. B. Kaur T. (2023). Standardised Ido-BR1 cucumber extract improved parameters linked to moderate osteoarthritis in a placebo-controlled study. Curr. Rheumatol. Rev. 19 (3), 345–351. 10.2174/1573397119666230206105703 36748212 Navid R. B. Karimi M. Ghojazadeh M. Bagherzadeh-Karimi A. Mohammadinasab R. Dolati S. (2023). Effect of Delphinium denudatum Wall. (Jadwar) on knee osteoarthritis: a randomized double-blinded placebo-controlled clinical trial . Pharm. Sci. 29 (3), 338–345. 10.34172/PS.2022.26 Olajide O. A. Iwuanyanwu V. U. Banjo O. W. Kato A. Penkova Y. B. Fleet G. W. J. (2022). Iminosugar amino acid idoBR1 reduces inflammatory responses in microglia. Molecules 27 (10), 3342. 10.3390/molecules27103342 35630818 Panahi Y. Rahimnia A.-R. Sharafi M. Alishiri G. Saburi A. Sahebkar A. (2014). Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytotherapy Res. 28 (11), 1625–1631. 10.1002/ptr.5174 24853120 Panahi Y. Alishiri G. H. Bayat N. Hosseini S. M. Sahebkar A. (2016). Efficacy of Elaeagnus Angustifolia extract in the treatment of knee osteoarthritis: a randomized controlled trial. Excli J. 15, 203–210. 10.17179/excli2015-639 27330526 Panda S. K. Nirvanashetty S. Parachu V. A. Mohanty N. Swain T. (2018). A randomized, double blind, placebo controlled, parallel-group study to evaluate the safety and efficacy of Curene® versus placebo in reducing symptoms of knee OA. Biomed Res. Int. 2018, 5291945. 10.1155/2018/5291945 30498758 Pinsornsak P. Niempoog S. (2012). The efficacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial. J. Med. Assoc. Thail. = Chotmaihet thangphaet 95 (Suppl. 1), S51–S58.23964444 Ramakanth G. S. H. Uday Kumar C. Kishan P. V. Usharani P. (2016). A randomized, double blind placebo controlled study of efficacy and tolerability of Withaina somnifera extracts in knee joint pain. J. Ayurveda Integr. Med. 7 (3), 151–157. 10.1016/j.jaim.2016.05.003 27647541 Rouse B. Chaimani A. Li T. (2017). Network meta-analysis: an introduction for clinicians. Intern Emerg. Med. 12 (1), 103–111. 10.1007/s11739-016-1583-7 27913917 Salanti G. Ades A. E. Ioannidis J. P. (2011). Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J. Clin. Epidemiol. 64 (2), 163–171. 10.1016/j.jclinepi.2010.03.016 20688472 Salimzadeh A. Alipoor E. Dehghani S. Yaseri M. Hosseini M. Feinle-Bisset C. (2018). The effect of 12-week garlic supplementation on symptom relief in overweight or obese women with knee osteoarthritis. Int. J. Clin. Pract. 72 (6), e13208. 10.1111/ijcp.13208 29790635 Schumacher H. R. Pullman-Mooar S. Gupta S. R. Dinnella J. E. Kim R. McHugh M. P. (2013). Randomized double-blind crossover study of the efficacy of a tart cherry juice blend in treatment of osteoarthritis (OA) of the knee. Osteoarthr. Cartil. 21 (8), 1035–1041. 10.1016/j.joca.2013.05.009 23727631 Sharma L. (2021). Osteoarthritis of the knee. N. Engl. J. Med. 384 (1), 51–59. 10.1056/NEJMcp1903768 33406330 Singhal S. Hasan N. Nirmal K. Chawla R. Chawla S. Kalra B. S. (2021). Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol. Trials 22 (1), 105. 10.1186/s13063-021-05053-7 33516238 Sontakke S. Thawani V. Pimpalkhute S. Kabra P. Babhulkar S. Hingorani L. (2007). Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee. Indian J. Pharmacol. 39 (1), 27–29. 10.4103/0253-7613.30759 Srivastava S. Saksena A. K. Khattri S. Kumar S. Dagur R. S. (2016). Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial. Inflammopharmacology 24 (6), 377–388. 10.1007/s10787-016-0289-9 27761693 Sumantran V. N. Chandwaskar R. Joshi A. K. Boddul S. Patwardhan B. Chopra A. (2008). The relationship between chondroprotective and antiinflammatory effects of Withania somnifera root and glucosamine sulphate on human osteoarthritic cartilage in vitro . Phytother. Res. 22 (10), 1342–1348. 10.1002/ptr.2498 18697233 Taheri M. Riahi S. M. Meybodi M. K. E. Ahmadian-Attari M. M. Esmaeili S. Mokaberinejad R. (2023). Effect of Squill oxymel on knee osteoarthritis: a triple-blind, randomized, controlled clinical trial. Traditional Integr. Med. 8 (2), 119–129. 10.18502/tim.v8i2.13077 Takeda R. Koike T. Taniguchi I. Tanaka K. (2013). Double-blind placebo-controlled trial of hydroxytyrosol of Olea europaea on pain in gonarthrosis. Phytomedicine 20 (10), 861–864. 10.1016/j.phymed.2013.03.021 23746949 Tudorachi N. B. Totu E. E. Fifere A. Ardeleanu V. Mocanu V. Mircea C. (2021). The implication of reactive oxygen species and antioxidants in knee osteoarthritis. Antioxidants (Basel) 10 (6), 985. 10.3390/antiox10060985 34205576 Walzer S. M. Weinmann D. Toegel S. (2015). Medical plant extracts for treating knee osteoarthritis: a snapshot of recent clinical trials and their biological background. Curr. Rheumatol. Rep. 17 (8), 54. 10.1007/s11926-015-0530-3 26163305 Wang Z. Efferth T. Hua X. Zhang X. A. (2022). Medicinal plants and their secondary metabolites in alleviating knee osteoarthritis: a systematic review. Phytomedicine 105, 154347. 10.1016/j.phymed.2022.154347 35914361 Wigler I. Grotto I. Caspi D. Yaron M. (2003). The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis. Osteoarthr. Cartil. 11 (11), 783–789. 10.1016/s1063-4584(03)00169-9 14609531 Yu G. Xiang W. Zhang T. Zeng L. Yang K. Li J. (2020). Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complement. Med. Ther. 20 (1), 225. 10.1186/s12906-020-02985-6 32680575 Zakeri Z. Izadi S. Bari Z. Soltani F. Narouie B. Ghasemi-Rad M. (2011). Evaluating the effects of ginger extract on knee pain, stiffness and difficulty in patients with knee osteoarthritis. J. Med. Plants Res. 5 (15), 3375–3379. Available online at: http://www.academicjournals.org/JMPR. Ziadlou R. Barbero A. Stoddart M. J. Wirth M. Li Z. Martin I. (2019). Regulation of inflammatory response in human osteoarthritic chondrocytes by novel herbal small molecules. Int. J. Mol. Sci. 20 (22), 5745. 10.3390/ijms20225745 31731767